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ABSTRACT.
The component forms of three hydrolytic enzymes, N-acetyl-
P-D-hexosaminidase, oc-D-glucosidase and (3-D-glucosidase, were
studied in certain tissues, cultured cells and fluids. The
possibility that hexosaminidases A and B had a common subunit and
differed by a subunit, which was also a constituent of the neutral
component, hexosaminidase C, was investigated and it was found
that hexosaminidase C was unlikely to be related to either of the
two major hexosaminidase components. The properties of another
minor component, hexosaminidase S, suggested that this may contain
the unique subunit of hexosaminidase A.
In addition to the a-glucosidase component deficient in
Pompe's disease, three other apparently genetically unrelated
components were identified. One of these, which had a neutral pH
optimum and little activity at pH 4-0 occurred in most tissues,
but was very labile. The others, one found in amniotic fluid and
the other in kidney and leucocytes, although having neutral pH
optima, had considerable activity at pH 4«0, thereby interfering
with the diagnosis of Pompe's disease.
The enzyme found to be deficient in Gaucher's disease was
associated with the (3-glucosidase activity eluting in the void
volume of Sephadex G-150. Two other more neutral components were
detected, one of which was also in the void volume and the other,
only present in some livers and in spleen, was of lower molecular
weight. Neither of these components was deficient in either of
the two cases of neuronopathic Gaucher's disease studied.
Methods were developed for detecting enzyme deficiencies
(iii)
when there were other components with hydrolytic activity towards
the artificial substrate, in the tissue being used. The DEAE-
cellulose batch method was the most useful for detecting hexosam¬
inidase A. Interfering a-glucosidase components were removed by
isoelectric precipitation at pH 5.0 the activity of the acid
a-glucosidase was determined indirectly using equations derived
on the basis of the relative susceptibility of components to
inhibitors. Non-specific (3-glucosidases residual in Gaucher tissues
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Inherited diseases in which certain intermediates of meta¬
bolism are either stored in tissues or excreted in excess in the
urine are usually caused by a deficiency of a particular enzyme
as proposed by Garrod (1923)» Subsequently, the concept that
each gene was responsible for one enzyme was formally proposed
(Beadle and Tatum, 1941)• An important group of these diseases
is that in which lysosomal enzymes are affected.
These enzymes, which have an acid pH optimum, are as their
name suggests located primarily within the lysosome, thus protect¬
ing the cell from their destructive properties. Complex biolog¬
ical molecules are taken up by the lysosomes to be broken down to
smaller molecules, and failure to degrade such complex molecules,
owing to a deficiency of a particular enzyme activity, may lead
to their storage in the lysosome (Hers, 1973)• Diseases which
have been attributed to deficiencies of particular lysosomal
enzymes include the Lipidoses, Glycogenosis Type II and the
Mucopolysaccharidoses.
The activities of many of the lysosomal enzymes may be
assayed using artificial substrates (Leaback, 1974)* These
mimic the natural substrate and when acted upon by the enzyme,
give rise to a chromagen or fluorogen, the concentration of
which may be measured using a spectrophotometer or fluorimeter
respectively, Artificial substrates, although easy to use, are
not very specific and several enzyme components may attack one
substrate, but have natural activities towards different substrates.
With some diseases, it has so far only been possible to detect the
enzyme deficiency using the natural substrate. An example of
this is Krabbe's Globoid Cell Leucodystrophy in which there is a
deficiency of galactocerebroside (3-galactosidase (Suzuki and
Suzuki, 1970). There is no deficiency of non-specific p-galacto-
sidase and the relationship between the specific and non-specific
enzyme forms is uncertain (Suzuki and Suzuki, 1974a and b;
Besley, 1975)- The development of more complex artificial subst¬
rates may lead to the spectrophotometric assay of these specific
enzymes (Gal et al., 1977).
The lack of specificity of a substrate allows the assay of
several enzyme components. These have been referred to as isoen¬
zymes. Although more than one enzyme component may attack an
artificial substrate, not all of these may attack the same natural
substrate. More than one enzyme component may be specific for the
same natural substrate and these too may be described as isoenzymes.
Given a definition based on function alone, isoenzymes may have a
common genetic origin or be totally unrelated. The term, isoenzyme,
is not very satisfactory and should be used with caution. It has
been suggested (Leaback, 1976) that the term, isoenzyme, should be
used only for enzymes attacking the same natural substrate and
that the term, enzyme component, should be used when describing
activities against artificial substrates.
Enzyme components may be tissue-specific. This may lead to
difficulties in diagnosis using certain tissues if interference
should occur from enzyme components, which have no activity
towards the natural substrate. This problem was encountered with
a-glucosidase in leucocytes (Koster et al., 1974) and will be
discussed in more detail later. Enzymes with similar natural
/
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function also differ from tissue to tissue. An example of this
is the different forms of hexosaminidase A found in tissues and
serum (ikonne and Ellis, 1973)• A study of the interrelationships
of these isoenzymes may prove to be of importance in understanding
the necessity for such specialisation.
The choice of enzymes studied in this thesis was to some
extent dependent on the availability of cells and post-mortem
tissues from patients, who had enzyme deficiencies. These were
N-acetyl-P-D-hexosaminidase (Tay-Sachs and Sandhoff's diseases),
acid a-glucosidase (Pompe's disease) and acid p-glucosidase
(Gaucher1s disease). Although cells from patients with other
diseases were available, the three enzyme systems chosen presented
problems of different types, which required varied techniques for
their investigation.
Two general approaches may be used when attempting to assay
the enzyme component, deficient in the disease, when other non¬
specific forms may be present. In the first approach, used in
this thesis for a-glucosidase and (3-glucosidase, the components,
which interfere with the assay, are removed. In the other
approach, the component to be assayed is selectively removed and
its activity calculated by difference. This method has been used
for estimating the heat and acid labile component A of hexosamini¬
dase (O'Brien et al., 1970; Saifer and Rosenthal, 1973).
Hexosaminidases A and B appeared to be genetically related
(Sandhoff et al., 1971) and it was also claimed that in some cases
of Pompe's disease (Angelini and Engel, 1972) and Gaucher's disease
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(Kanfer et al., 1975)> activities other than those of the acid
components were affected, implying that these other forms and the
acid forms may be related. The genetic relationships of components
will be investigated as will the possible natural function of
non-specific hydrolases. Examples of the diagnosis of each of the
diseases, both antenatally (if encountered) and postnatally will




DEFICIENCY IN G„„ GANGLIOSIDOSISM2
THE G
^ GANGLIOSIDOSES AND THEIR ASSOCIATED ENZYME DEFICIENCIES.
In 1881, Tay, a British ophthalmologist reported changes in
the macular in the eyes of an infant. He subsequently reported
these changes in other patients, including three in the same
family (Tay, 1884; 1892). This change, which is now described as
the cherry red spot, is in fact an artifact of degeneration of the
retina around this spot. Sachs, an American neurologist, reported
a form of familial idiocy, associated with early blindness (Sachs,
1887; 1896). This became known as Tay-Sachs disease. The first
recognised cases of this disease were in Jewish families, but, as
more cases were reported, the disease was also found in non-Jewish
families.
Klenk (1939) showed that there was an accumulation of gangli-
osides in Tay-Sachs brain and concluded that the disease was due
to a disorder of sphingolipid metabolism. Gangliosides are complex
glycosphingolipids that contain one or more sialic acid residues
and are found primarily in the central nervous system. Svennerholm
and Raal (1961) reported the presence of excessive amounts of
monosialogangliosides in Tay-Sachs brain. This was shown
(Svennerholm, 1962) to be attributable to the storage of
ganglioside, which was formed after the removal of the terminal
galactose moiety from the major normal monosialoganglioside (G^)*
Furthermore, it was also shown that the level of the asialo form
of G^ ganglioside (G^) was raised in Tay-Sachs brain. The
interrelationship of the various sphingolipids is shown in the
appendix (page 255).
It was expected that the storage of these materials would
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eventually be found to be due to a deficiency of a particular
catabolic enzyme. Frohwein and Gatt (19&7) extracted such an
enzyme, N-acetyl-P-D-hexosaminidase, from calf brain and this was
found to degrade G^ ganglioside, extracted from Tay-Sachs brain.
It was likely that patients with Tay-Sachs disease would be found
to be deficient in N-acetyl-(3-D-hexosaminidase activity. This
was not so, however, apart from one exceptional patient, who also
had storage of kidney globoside (Sandhoff et al., 1968).
Human hexosaminidase was found to exist as two major compon¬
ents, A and B (Robinson and Stirling, 1968) and this finding gave
impetus to investigations into Tay-Sachs disease. Okada and
O'Brien (19&9) Hultberg (19&9) reported the deficiency of
hexosaminidase component A in Tay-Sachs disease. Furthermore, it
was shown that components A and B were able to degrade G^ and
globoside, whereas only component A was able to degrade G^
(Sandhoff, 1970).
The two major forms of G^ gangliosidosis are type B and
type 0. The former is more common and is usually known as Tay-
Sachs disease; the latter is known as Sandhoff-Jatzkewitz disease
or simply Sandhoff's disease. It is possible that there might be
some variation within these groups, but the major difference
between the two forms of the disease is that Sandhoff patients
have an almost total deficiency of N-acetyl-|3-D-hexosaminidase,
whereas Tay-Sachs patients lack only component A. A large
proportion of Tay-Sachs patients are of Jewish descent, but
Sandhoff patients are panethnic. Two variant forms of Tay-Sachs
disease have been reported. Sandhoff (19^9) reported one case
with increased activity of hexosaminidases A and B in brain.
This patient was diagnosed clinically as Tay-Sachs disease and
shown to store G^ and no^ gloloside (Sandhoff et al. ,
1971)• In juvenile Tay-Sachs disease the activity of component A
(Hex-A) was partially reduced (Young et al., 1970)•
It was suggested (Sandhoff et al., 1971) that there was some
genetic relationship between components A and B. If this were
not so, it would be necessary to postulate that Sandhoff's disease
was the result of two separate deficiencies. As Sandhoff's
disease accounted for approximately one third of the cases of G^
gangliosidosis and was not linked to the Jewish population, this
was not a very likely explanation.
To explain the dual enzyme deficiency in Sandhoff's disease,
several theories may be put forward. The genes for components
A and B may have been adjacent on the same chromosome and the
deficiency in Sandhoff's may have been caused by a deletion of
all or part of both genes. The gene for Hex-B has been shown to
be located on the fifth chromosome, whereas genes on the fifth
and fifteenth chromosomes were necessary for component A (Lalley
et al., 1974» Gilbert et al., 1975)• It was possible that a
deletion across two genes on chromosome 5 could have led to the
deficiency in Sandhoff's disease. As yet, no cases have been
reported, which were deficient in Hex-B only and so theories in
which Hex-A was dependent on the presence of Hex-B were favoured.
One possibility was that Hex-B was an intermediate in the
synthesis of Hex-A. This satisfied the condition that Hex-A was
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present only when Hex-B was also present. If Sandhoff patients
did not have active component B, then they could not be expected
to make component A. Tay-Sachs patients, on the other hand, have
Hex-B, but would lack the capacity to convert it to component A.
Another suggestion (Tateson and Bain, 1971) was that in Tay-Sachs
disease, Hex-B was altered sufficiently to block its conversion
to Hex-A, but not to affect its enzyme activity.
In order to understand the possible relationship between
hexosaminidases A and B, a study of their properties was under¬
taken (Robinson and Stirling, 1968; Sandhoff, 1968; Poenaru and
Dreyfus, 1973). Hex-B was heat stable, moved slowly towards the
anode on electrophoresis at pH 6.5? was unbound to BEAE-cellulose
at pH 6.0 and had an isoelectric point of pH 7~8. Hex-A, although
having a similar molecular weight to component B, was relatively
heat labile, moved more rapidly towards the anode on electrophor¬
esis, was bound to BEAE-cellulose and had an isoelectric point of
pH 5-5.5.
To explain the difference in charge between the two
components, it was suggested that Hex-A differed from Hex-B in
its sialic acid content. To test this hypothesis, Hex-A was
purified and treated with neuraminidase (Robinson and Stirling,
1968; Murphy and Craig, 1972). The product was found to have an
electrophoretic mobility similar to that of component B and the
theory that Hex-A was synthesised from Hex-B by the addition of
sialic acid residues, gained some support. Subsequently it was
found that the conversion of Hex-A to Hex-B was unrelated to
neuraminidase activity (Tallman et al., 1974). Using neuramin-
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idase prepared from Clostridium perfringens, it was observed that
more N-acetyl-neuraminic acid was released when Hex-A was incub¬
ated with enzyme for one week at lower temperatures rather than
at 37°C. Only at 37°C, however, was much Hex-B formed. This
showed that the conversion of Hex-A to Hex-B was unrelated to the
release of N-acetylneuraminic acid. Furthermore, it was shown
(Carmody and Rattazzi, 1973) that using a preparation of Vibrio
cholerae extract, containing neuraminidase, similar to that used
by earlier workers, conversion occurred even after heat inactiv-
ation of the neuraminidase. The conversion was found to be due
to the presence of a preservative, merthiolate, in the commercial
Vibrio cholerae extract and that p-hydroxymercuribenzoate and
silver ions were also able to convert Hex-A to Hex-B (Beutler
Villacorte et al., 1975) -
In another theory, it was proposed that hexosaminidases A
and B shared a common subunit. The conversion of Hex-A to Hex-B
would then be explained by dissociation into subunits, accelerated
by the presence of -SH reagents. It was proposed that in
Sandhoff's disease, the subunit, common to both enzyme components,
was absent, whereas in Tay-Sachs disease, the deficiency was of a
subunit of Hex-A alone. This theory gave rise to two possibilities,
a two locus or a three locus model. In the two locus model, it
was proposed that Hex-B was composed of several subunits of the
same type, whereas Hex-A was composed of two types of subunit,
one of which was also present in Hex-B. In the three locus model,
Hex-A was composed of two different types of subunit, one in
common with Hex-B and one unique. Component B also had two types,
one of which was unique.
Hex-A Hex-B
Two locus model ^^n
Three locus model ^^n
These alternatives were discussed by Srivastava and Beutler
(1973; 1974)• In support of the three locus model, it was
reported (van Someren and van Henegouwen, 1973) that in Chinese
hamster-human fibroblast hybrids, hexosaminidases A and B could
be lost independently of each other. Lalley et al. (1974)
refuted this, however, and found that no hybrid clones had Hex-A
activity in the absence of Hex-B. This later data supports the
two locus model.
The subunit theory predicted that Sandhoff patients would
still have the unique subunit of Hex-A and in search of this
subunit, the residual hexosaminidase activity in Sandhoff tissues
was investigated. An enzyme component attracting interest was
Hex-C, which was first reported by Hoogwinkel et al. (1972) in
studies on human brain. Poenaru and Dreyfus (1975) showed that
Hex-C was present in all human tissues and was more anodic than
Hex-A on "Cellogel" electrophoresis. It was, indeed, a very good
candidate for the unique subunit in Hex-A. Sandhoff patients did
have Hex-C (Galjaard et al., 1974) and. it had been claimed that
Tay-Sachs tissues were deficient in this enzyme (Hoogwinkel et al.
1972). These two findings were necessary conditions if the
subunit, unique to Hex-A, was also in Hex-C. When Tay-Sachs
fibroblasts were hybridised with Sandhoff fibroblasts, hybrid
cells were obtained, which now had Hex-A as well as Hex-B and
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Hex-C (Galjaard et al., 1974)* This was not evidence in itself
for the subunit theory, as any theory based on the premise that
the lesions in Tay-Sachs and Sandhoff's disease were complementary,
would be supported by this result. In view of these findings, the
significance of Hex-C in the G^ gangliosidoses was investigated
and the results are reported in this thesis.
It would now appear that Hex-C is present in Tay-Sachs tissues
(Penton et al., 1975) as well as in Sandhoff tissues. Consequently
it would seem unlikely to contain the subunit unique to Hex-A.
This subunit is probably contained in another form of hexosamin¬
idase, recently found in Sandhoff tissues and termed Hex-S
(Beutler, Kuhl et al., 1975» Ikonne et al., 1975)• In view of the
possible significance of this component, its properties were
determined and will be considered in this thesis.
With the discovery of the deficiency in Tay-Sachs disease
came the development of routine techniques for the detection of
Hex-A. Two approaches have been used when differentiating
between components A and B. One approach was dependent on the
lability of Hex-A relative to Hex-B on heat treatment (Robinson
and Stirling, 1968) or at acid pH (Saifer and Rosenthal, 1973)-
Alternatively, the difference in isoelectric point between the
two components was used (Sandhoff, 1968) and Hex-A was detected
by ion-exchange methods (Young et al., 1970) or by electrophor¬
esis (Robinson and Stirling, 1968). Methods of heat or pH
inactivation have been adapted for the analysis of large numbers
of samples (O'Brien et al., 1970; Saifer and Perle, 1974)- This
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was particularly useful for heterozygote screening in areas
where the Jewish population was large.
Control tissues and serum were found to lose hexosaminidase
activity when heated or preincubated at acid pH prior to assay,
whereas in Tay-Sachs disease little or no activity was lost,
owing to the absence of Hex-A and consequent preponderance of
Hex-B. It was reported (Tallman et al., 1974) that, on heating,
Hex-A was converted to Hex-B with some loss of activity. If
Hex-A were converted to Hex-B, the percentage A would be under¬
estimated. Electrophoretic methods provide a good visual demon¬
stration of the presence or absence of Hex-A, but are not easily
adapted to give a quantitative result, essential for heterozygote
detection. If a quantitative result were required, either the
electrophoretogram could be sliced into sections for assay or a
preparative column could be used. Neither of these procedures is
as straight forward as inactivation techniques. Similarly,
isoelectric focusing may be used, either in polyacrylamide gels
or for a more quantitative result in a sucrose gradient. Using
this technique, it was possible to clearly separate components A
and B as well as other minor components (Sandhoff et al., 1971)•
This again was not a very good routine method. The same might be
said of ion-exchange methods. Dance et al.,(19^9) reported that
Hex-B was was unbound to DEAE-cellulose, whereas Hex-A was bound
but could be eluted with a linear gradient of sodium chloride.
The method has been automated, however, to give it some of the
advantages of the heat method but with a more accurate determin¬
ation of Hex-A (Ellis, Ikonne and Masson, 1975). The automated
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HEAE-cellulose column also provided information about other
hexosaminidase components, undetected by inactivation methods.
DEAE-cellulose could also be used in a batch method, which made
use of the binding property of the resin in the test tube (Dance
et al., 1570)• Hex-B was not bound at low chloride concentration,
whereas Hex-A was only free in the presence of higher concentrations
of anion. This method proved to be particularly useful when small
numbers of samples were being screened for Tay-Sachs disease.
The different methods of determining Hex-A were compared in this
study.
Minor components of hexosaminidase have been investigated.
Price and Dance (1972) reported that two minor components were
eluted between hexosaminidases A and B on EEAE-celiulose. These
components, designated 1^ and I^, were found particularly in
serum instead of Hex-B. Stirling (1972) found a major intermed¬
iate component of hexosaminidase in the serum of pregnant women.
This, he designated Hex-P and on the basis of its electrophoretic
mobility, which was towards the anode but slower than Hex-A, its
behaviour on DEAE-cellulose and heat stability, suggested that it
might be identical with Hex-I^.
Human serum Hex-A was shown to consist of two components
(ikonne and Ellis, 1973)* The minor component was apparently
identical to tissue Hex-A. The major Hex-A component of serum
was eluted from DEAE-cellulose at a lower salt concentration than
the tissue form and if multiple pass Sephadex G-150 gel filtration
was employed, the major serum component was eluted before tissue
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Hex-A. These workers also found, that, although tissue Hex-A was
/
unaltered after treatment with neuraminidase derived from
Clostridium perfringens, serum Hex-A was converted to a form
which was eluted from EEAE-cellulose earlier than the native
enzyme. Serum Hex-A was not converted to tissue Hex-A by neuram¬
inidase treatment and was not, therefore, merely a sialated form
of tissue Hex-A, Hex-A was found to be deficient in the serum of
patients with Tay-Sachs disease (Okada and O'Brien, 1969) so
serum and tissue forms appear to be closely related. The inter¬
mediates, now known as hexosaminidases 1^ and I^, were present in
the tissues of patients with Tay-Sachs disease (Young et al.,
1970), so these were more likely to be related to Hex-B.
Ellis and Patrick (1976) have studied the distribution of
hexosaminidases in human leucocytes. They found that the Hex-A
peak of leucocytes on DEAE-cellulose was eluted similarly to that
of grey matter, but that the peak was asymmetric, suggesting that
another component, eluting just before this peak, was present.
Examination of separated lymphocytes and polymorphonuclear cells
(PMN), revealed that the Hex-A in PMN was eluted similarly to that
total leucocytes, although the activity of Hex-B was much higher
in the latter. The Hex-A in lymphocytes, however, was eluted
after that of total leucocytes or PMN. The activity of Eex-B was
higher in lymphocytes than in PMN and it was pointed out that
problems could be encountered in screening for Tay-Sachs carriers
using leucocytes, since the percentage Hex-A was dependent on the
relative proportions of lymphocytes and PMN. The results of
isoelectric focusing studies, which led to a better resolution of







pyranoside (0.5mM) (Koch-Light Labs. Ltd.) were the substrates
for N-acetyl-j3-L-glucosaminidase and N-acetyl-f3-L-galactosamin-
idase respectively. For the standard assay, substrate at double
the final concentration required, was dissolved in phosphate-
citrate buffer (0.2M/0.1M), pH 4«5> (Mcllvaine, 1921) containing
Triton X-100 (O.V/oV/v) and sodium azide (0.02%w/v). Buffer-
substrate mixture (1 vol.) was mixed with extract (1 vol.) in
an LP3 tube (Luckham Ltd.) and incubated at 57°C. After
incubating the mixture for a known period of time, the reaction
was stopped with 0.1M-sodium carbonate and the fluorescence read
as described in the appendix (page 242).
For the pH profile, substrate dissolved in distilled water
at four times the final concentration (1 vol.) was added to
double strength buffer (1 vol.) and the assay was started with
extract (2 vols.). Protein was determined (Lowry et al., 1951)
as described in the appendix (page 245), using bovine serum
albumin (Sigma Ltd.) as standard.
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Enzyme source and preparation of extract.
/
(i) Cultured ceils.
Amniotic fluid cells and skin fibroblasts were cultivated as
described in the appendix (page 244). When it was important to
remove the hexosaminidase activity of the fetal bovine serum
in the medium, the serum was incubated at 6o°C for two hours.
The serum was filtered through a millipore filter before adding
to the medium. —
(ii) Blood samples.
Leucocytes were usually isolated using dextran as described
in the appendix (page 247)• This method preferentially isolated
polymorphonuclear cells. If lymphocytes were required, these
were isolated using Ficoll-Paque, also described in the appendix
(page 248).
Serum was prepared by low speed centrifugation (900g) of
clotted blood.
(iii)Post-mortem tissues.
Tissues, liver and brain, were stored at -40°C until
required. These were obtained within 24 hours of death.
Cultured cells and white blood cells were disrupted by
sonication using a "Soniprobe" (Dawe's Instruments) and
centrifuged (900g for 5 mins.). Tissues were homogenised using
either a Potter-Elvehjem all glass homogeniser or a mixer
emulsifier (Silverson Machines Ltd.), sometimes followed by




DEAE-cellulose was prepared as described in the appendix
(page 250) and equilibrated with 10mM-sodium phosphate buffer,
pH 6.8, for all routine work. The sample was applied to a
column (12 x 0.8cm. diam.) packed with DEAE-cellulose and
unbound material eluted with 10ml buffer. Fractions (1ml) were
collected. A linear chloride gradient was applied at a flow rate
of 20ml/h and 40 fractions (1ml) were collected up to a chloride
concentration of approximately 350mM.
For the DEAE-cellulose batch method, the following reagents
were added to an LPJ tube (Luckham Ltd.).
Hexosaminidase
B AB
DEAE-cellulose slurry 0.3ml 0.3ml
Cell extract 0.05ml 0.05ml
NaCl in buffer (0.32M) 0.05ml
NaCl in buffer ( 2M ) 0.05ml
The tubes were capped and mixed (4°C) on an angled rotary
mixer for 15 minutes. After mixing, the slurry was separated
from the supernatant by centrifugation (900g for 2 mins.). The
supernatant was assayed for hexosaminidase activity and the
percentage hexosaminidase A was calculated by difference.
(ii) Isoelectric focusing.
The method used for isoelectric focusing, an adaptation of




Electrophoresis on "Cellogel" strips (Reeve Angel Scientific
Ltd.) was by the method of Poenaru and Dreyfus (1973) • The
strips were wet with 40mM-potassium phosphate buffer, pH 6.5.
Excess buffer was removed from the surface and sample (25ul) was
applied using a Lang-Levy constriction pipette. A voltage of
200 volts (15 v/cm) was applied for two hours at 4°C.
At the end of the run, the strips were placed face down on
Whatman JMM chromatography paper, soaked in buffered substrate
and incubated in a warm humid atmosphere. When it was adjudged
that sufficient 4-methylumbelliferone had been released, the
strips were exposed to ammonia vapour and the fluorescence
visualised using a UV. light source.
Heat inactivation.
For the heat inactivation method for the estimation of
percentage hexosaminidase A, extract was mixed with bovine serum
albumin (BSA) and buffer as follows:-
enzyme blank
Tissue or cell extract O.Jml
Distilled water O.Jml
BSA (jmg/ml) O.Jml O.Jml
Sodium citrate buffer (0.1M), pH 5.0 at 50°C 0.6ml 0.6ml
These mixtures were incubated at 50°C and aliquots (lOOpl)
were removed and stored at 4°C at intervals of 0, 10, 20, JO, 45»
60, 120 and 240 minutes. An aliquot (25pl) for each time point
was assayed in duplicate for hexosaminidase activity. After
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subtracting the blanlc activity, the °f "the percentage
activity remaining was plotted against time. The slope of the
second phase of the biphasic plot was extrapolated to zero time
to estimate the percentage hexosaminidase B in the original
mixture and from this the percentage hexosaminidase A was
calculated.
Initially ordinary bovine serum albumin (Sigma Ltd.) was
used but this had too high a hexosaminidase activity for later
experiments in which lower activities were being investigated.
It was suggested (R.B. Ellis, personal communication) that a
lower blank would be encountered if BSA fraction V was used but
this too had an unacceptably high blank. It was, however,
possible to separate the hexosaminidase activity in BSA fraction
V from most of the protein by Sephadex G-150 gel filtration
(Figure 1a, page 23). The column (35 x 3cm diam.) was eluted
with S^-sodium phosphate buffer, pH 7«0, containing 5^-^01,
the hexosaminidase activity eluting after the major protein peak
The hexosaminidase-free BSA was dialysed against distilled water
concentrated by vacuum dialysis and lyophilised.
Not only had the purified BSA a low blank but gave better
biphasic heat inactivation plots (Figure 1b, .page 23). This was
not attributable to the removal of bovine hexosaminidases, as












FIGURE 1 . (a) Sephadex G-200 gel filtration of 500mg BSA
fraction V to remove hexosaminidase activity.
protein hexosaminidase
(b) Hexosaminidase heat inactivation plot for control
liver using distilled water instead of BSA (•), BSA fraction V (■)
and BSA fraction V after gel filtration (a) .
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Preparation of hexosaminidase C.
Brain (80g) from a stillborn anoxic infant was homogenised
using a mixer emulsifier (Silverson Machines Ltd.) in lOmM-sodium
phosphate buffer, pH 6.0, containing Triton X-100 (0.1%V/v) and
sodium azide (0.02% /v). The homogenate was centrifuged (900g
for JO minutes at 4°G) and the supernatant was concentrated
tenfold by vacuum dialysis. After centrifuging once more (10 OOOg
for 30 minutes at 4°C), the supernatant (2ml) was applied to a
Sephadex G-200 column (90 x 4*4cm diam.), equilibrated with the
same buffer in which the tissue had been homogenised. The column
was eluted at an ascending flow rate of 24ml/h and fractions
(8.1ml) were collected. Fractions were assayed for N-acetyl-P-
D-glucosaminidase activity at pH 4*5 and pH 5«5« The first peak
had more activity at pH 5«5 than at pH 4»5j whereas the second
peak had the greater activity at pH 4«5« Hexosaminidase C
(peak; I) and peak II were taken for further studies.
/
Preparation of hexosaminidase S.
Normal human liver (ig) was homogenised in 0.1%V/v
Triton X-100 (3ml) using a Potter-Elvehjem all glass hand
homogeniser. The homogenate was then sonicated and centrifuged
at 800g for 5 minutes (4°C). The supernatant was adjusted to
pH 5.0 with sodium acetate buffer and centrifuged once more at
800g for 5 minutes (4°C). The supernatant (2.5ml) was dialysed
at 4°C against 10mM-sodium phosphate buffer, pH 6.0, containing
0.05^V/v Triton X-100 and 0.02%W/v sodium azide. After low
speed centrifugation, the supernatant was applied to a DEAE-
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cellulose column (40 x 2cm diam.), equilibrated with the buffer
used for dialysis. After twenty fractions (5ml) had'been
collected, a chloride gradient was applied to the column and a
further eighty fractions (5ml) were collected. Selected
fractions were taken from the tail of the hexosaminidase A peak,
dialysed against distilled water and focused. Hexosaminidase S,
relatively free of other hexosaminidase components was obtained.
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(a) STUDIES ON HUMAN HEXOSAMINIDASES.
RESULTS.
(i) Binding of hexosaminidases to DEAE-cellulose.
When homogenates were applied to a DEAE-cellulose column,
two major peaks of activity were eluted, corresponding to
hexosaminidases A and B. A typical plot is shown in Figure 2 ,
where a homogenate prepared from cells cultured from human urine











10 20 50 40
fraction number (1.1 ml)
FIGURE 2. Separation of cultured urine cell hexosaminidases
on DEAE-cellulose.
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before the chloride gradient was applied and the larger peak,
Hex-A, was eluted at 145mM-sodium chloride. A minor, broad peak
of activity was eiuted as soon as chloride was applied to the
column. The percentage Hex-A was estimated by DEAE-cellulose
column chromatography, the DEAE-cellulose batch method or by
heat inactivation (Table 1 ). Using commercial lyophilised
bovine serum albumin, the heat inactivation method consistently
underestimated Hex-A activity, compared with the other two
•methods which gave closely similar results.
When the activity of hexosaminidase was measured in
cultured cells, it was found that the activity of cultured skin
fibroblasts was -not greater than that of- Ctfl tured ammo tic fluid and
urine cells (Table 2 , page 28 ). It was also found that the
TABLE 1 Comparison of the three methods used for the estimation
of percentage hexosaminidase A.
i Cell % Hex-A*
extract Heat BEAE-cellulose LEAE-cellulose
inactivation batch column
1 58 77 74
2 53 80 80
5 6o 71 72
4 53 69 65
5 46 73 73
6 41 48 48
* Activity of hexosaminidase A expressed as a percentage of total
activity.






























percentage Hex-A, determined using the BEAE-cellulose batch
method, was lower in cultured skin fibroblasts than in the other
two cell types. As Hex-A had a similar specific activity in all
three cell types, the greater total activity in cultured skin
fibroblasts was attributable to Hex-B. A particularly
interesting observation was that morphologically fibroblastic
amniotic fluid cells did not differ from epithelioid cells with
respect to the two major enzyme components.
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(ii) Separation of hexosaminidases by isoelectric focusing.
Isoelectric focusing was the most effective means of
separating the various component forms of hexosaminidase. The
isoelectric points of hexosaminidases A and B of cultured skin
fibroblasts were pH 5• 5 and. pH 8.2 respectively (Figure 3 )•
No other components were seen. The isoelectric point of serum
Hex-A was pH 5•0; several peaks with higher isoelectric points
were also present (Figure 4a, page 31 )• When serum from a
pregnant woman was focused, the major hexosaminidase component
(Hex-P) had an isoelectric point of pH 6.5 (Figure 4b, page 31 ).
Isoelectric focusing of liver homogenates gave two major
peaks of activity corresponding to the hexosaminidases A and B
found in cultured skin fibroblasts (Figure 5 ? page 32).
Sometimes a smaller peak at pH 6.5 was also detected. The
profile in brain was somewhat different. A neonatal brain
PH
FIGURE 3 • Isoelectric focusing in the range pH 3-5-10.0 for




FIGURE 4 . Isoelectric focusing in the range pH 3-5-10.0 for
(a) control human serum and (b) control human pregnancy serum.
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pH
FIGURE 5 • Isoelectric focusing in the range pH 3.5-10.0 for
control human liver.
pH
FIGURE 6 . Isoelectric focusing in the range pH 3.5-10.0 for
control neonatal human brain.
assayed at pH 4*5
----- assayed at pH 5*5
homogenate was focused and gave rise to a sharp peak of hexosam¬
inidase with pi 5.2, together with a broad band of activity which
peaked at pH 6.5-7*5 (Figure 6, page 52). There was no peak
corresponding to the hexosaminidase B normally present in
cultured skin fibroblasts and liver. When assayed at pH 4•5»
the peak with pi 5.2 was skewed towards a higher isoelectric
point, but when the fractions were assayed at pH 5«5» this peak
was skewed in the opposite direction.
Differences have been found in the hexosaminidase components
of lymphocytes and polymorphonuclear cells (PMN) using DEAE-
cellulose chromatography (Ellis and Patrick, 1976). Isoelectric
focusing was thought to be a more useful tool for investigating
these differences. The patterns for lymphocytes and PMN were
not dissimilar (Figure 7> page 54). The major difference was
that the peak with the lowest isoelectric point occurred in the
PMN only. This had an isoelectric point around that of Hex-S
(see Figure 16, page 44). Peak II, the major peak in the two
lymphocyte preparations tested and in one of the PMN preparations
(second largest to peak I in the other), corresponded very closely
to serum Hex-A. Component IY was probably tissue Hex-A, whilst
components III and Y, which only appeared as shoulders, did not




















FIGURE 7 • Isoelectric focusing in the range pH 4.0-6.0 of
lymphocyte (■) and. polymorphonuclear cell (•) hexosaminidases
from two control blood samples.
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(iii)Hexosaminidase C.
Hexosaminidase C was obtained from the brain of a stillborn
anoxic infant. The enzyme was separated from other hexosamini¬
dase components by Sephadex G—200 gel filtration (Figure 8 ).
The column had previously been calibrated using Blue Bextran and
Hex-G was adjudged to be just included.
■ The isoelectric focusing profile of the first peak of
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fraction number (8.1 ml)
FIGURE 8 . Separation of neonatal human brain hexosaminidases
by Sephadex G-200 gel filtration. 300 ml were collected before
fraction 1.
assayed at pH 4«5




FIGURE 9 • Isoelectric focusing of the peaks of hexosaminidase
obtained from Sephadex G-200 gel filtration of neonatal brain.
a) Peak I in the range pH 3.5-10.0 assayed at pH 5.5*
b) Peak II in the range pH 3*5-10.0 assayed at pH 4*5.
c) Peak I in the range pH 4.0-6.0 assayed at pH 5«5«
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at pH 4*77 (Figure 9a, page 36). Peak; II gave two focusing
peaks with isoelectric points of pH 5-27 and. pH 7-40, corresp¬
onding to tissue Hex-A and a component with an isoelectric
point lower than that of the Hex-B of liver and cultured skin
fibroblasts (Figure 9b, page 36). When peak I was focused in
the range pH 4-0-6.0, the isoelectric point of the hexosaminidase
peak was pH 4-80 (Figure 9c, page 36).
In order to show that peak I was the same as Hex-C
described previously (Poenaru and Dreyfus, 1973)> electrophoresis
was carried out. Difficulties were encountered when concentrated
peak I was applied to "Cellogel" strips, as the presence of
residual Triton X-100 caused the sample to run on the surface
of the strip. Prolonged dialysis against distilled water led to
precipitation of the enzyme. Dialysis against 10mM-sodium
phosphate buffer, pH 7-0, containing 0.1M-sodium chloride
resulted in some loss of activity but after low speed centrifug-
ation, the sample was suitable for electrophoresis. Peak I
hexosaminidase was more anodic than Hex-A, corresponding to
Hex-C (Figure 10 , page 38).
The pH profile of Hex-C had an optimum of pH 5-5-6.0
(Figure 11, page 39). The activity fell away sharply on the
acid side of the peak and at pH 4-5 was only 11% of the maximum.
The apparent was determined for peaks I and II using
both the glucosaminide and galactosaminide conjugates of methyl-
umbel liferone. Assayed at pH 4-5 > "the apparent K^s for peak II
were 0.88mM and 0.1l6mM for glucosaminide and galactosaminide





FIGURE 10 . "Cellogel"
inidases showing peak I
electrophoresis of neonatal brain hexosam-




FIGURE 11. Activity (%) v. pH plot for peak I hexosaminidase
from Sephadex G-200 gel filtration of neonatal brain.
assayed at pH 5-5 were 0.50mM and 0.81mM (Figure 12, page 40).
Under the conditions used for the standard assay, the ratio of
glucosaminidase activity to galactosaminidase activity was 31
for Hex-C.
12 3 4 5
~ (nM~1)
s (^'1)
FIGURE 12. Lineweaver-Burk double reciprocal plots for the
determination of apparent K . Peak I (■) was assayed at pH 5*5
whereas peak II (•) was assayed at pH 4«5«
a) Using 4-methylumbelliferyl-2-acetamido-2-deoxy-|3-D-
glucopyranoside as substrate. for peak I = 0.50mM and for
peak II = 0.88mM.
b) Using 4-niethylumbelliferyl-2-acetamido-2-deoxy-(B-D-
galactopyranoside as substrate. for peak I = 0.81mM and for
peak II = 0.1l6mM.
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(iv) Hexosaminidase S.
For the preparation of Hex-S, liver hexosaminidases were
separated by HEAE-cellulose column chromatography (Figure 13).
50 68 100
fraction number (5 ml)
FIGURE 13. Separation of liver hexosaminidases with a view
towards preparation of a fraction rich in hexosaminidase S by
EEAE-cellulose column chromatography.
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Fractions 68 and. 69 were taken separately, dialysed against
distilled water and used for focusing. The isoelectric focusing
profile of fraction 68 (Figure 14) had three peaks of hexosamin¬
idase activity with isoelectric points of pH 4«42» pH 5.02 and
pH 7.45.
PH
FIGURE 14. Isoelectric focusing of
cellulose column (Figure 13 ) in the
fraction 68 from the DEAE-
range pH 3.5-10.0.
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The fractions at pH 4*26 and pH 4«42 were pooled and the
heat stability of hexosaminidase in these fractions compared
with that of hexosaminidases A and B (Figure 15). Hex-A had a
time at 50°C (min)
FIGURE 15 . Heat inactivation plots of the peak corresponding to
pH 4«42 in Figure 14 (A) and hexosaminidases A (®) and B (■) .
half life of about eight minutes, Hex-B was stable and the
pooled fractions from the focusing column, believed to be mainly
Hex-S, gave a biphasic plot. Most of this Hex-S peak (855^) was
very heat labile with a half life of about eight minutes, but a
minor component with a half life of about forty minutes was also
present. In a pilot experiment, this minor component had been in
excess of thirty percent of the activity. A further purification
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step was considered to be necessary before meaningful KffiS could
be obtained.
Accordingly, fraction 69 from the IEAE-cellulose column
was focused in the range pH 4*0-6.0 and three peaks of activity
at pH 4.43, pH 4*80 arid pH 5.07 were obtained (Figure *16).
pH
FIGURE 16. Isoelectric focusing of fraction 69 (Figure 13 ) in
the range pH 4.0-6.0 (•) and refocusing of fractions corresponding
to pH 4.00, 4.12, 4.21, 4.30 and 4-43 (■).
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These latter two were probably hexosaminidase A of serum and
tissue respectively. Fractions between pH 4-00 and pH 4-43 were
dialysed against distilled water and refocused (Figure 16,
page 44)« The major peak of hexosaminidase had an isoelectric
point of pH 4-38 and. there were two smaller peaks at pH 4-13 and
pH 4.84. The fractions at pH 4-38 and 4-31 were pooled and used
for a pH profile and for the determination of the apparent Km
with both glucosaminide and galactosaminide conjugates.
The pH profiles for hexosaminidases A, B and S are shown in
Figure 17 (page 48). Hexosaminidases A and S both had optimal
activity at pH 4»5> but the profile for component S was sharper
especially on the neutral side. Hex-B had an optimum at
pH 4.0-4.5.
The apparent at pH 4*0 was determined from the best
straight line through a double reciprocal plot calculated by
regression. The kinetics were studied at pH 4.0 because it was
felt that subsequent studies on Sandhoff fibroblasts would have
to take into account possible interference from Hex-C. The
Lineweaver-Burk plots for hexosaminidases A, B and S are shown
in Figure 18 (page 47 )• The apparent for Hex-S was found to
be 10.5mM for glucosaminidase activity and 0.78mM for galactos-
aminidase activity. For Hex-A, the apparent was 2.4mM for
glucosaminidase and 0.23mM for galactosaminidase, and for Hex-B
1.0mM and 0.124mM respectively.
Attempts to produce Hex-S from either hexosaminidase A or B
failed. Using the method of Beutler and Kuhl (1975)> Hex-A and
Hex-B were each frozen and thawed three times in 20mM:-sodium
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FIGURE 17« Activity (%) v. pH plots for hexosaminidases A (®) ,
B (■) and S (a) .
phosphate buffer, pH 7.0, containing JM-sodium chloride. In
neither case was an extra peak of any significance produced
(Figure 19 » page 48). The conditions, however, were not quite
as in the experiment described by Beutler and Kuhl (1975) in
that the activity of the enzyme used was but a fifth of that
recommended.
FIGURE 18 . Lineweaver-Burk double reciprocal plots for the
determination of apparent for hexosaminidases A (©), B (u) and
S (a) when assayed at pH 4^0.
a) Using 4-methylumbelliferyl-2-acetamido-2-deoxy-p-D-
glucopyranoside as substrate. for A = 2.4mM, B = 1.0mM and
S = 10.5mM.
b) Using 4-methylumbelliferyl-2-acetamido-2-deoxy-3-D-
galactopyranoside as substrate. for A = 0.23mM, B = 0.124mM
and S = 0.78mM.
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FIGUBE 19. Isoelectric focusing of human liver hexosaminidases
A (a) and B (h) in the range pH 3.5-10.0 after three cycles of




(i) Estimation of hexosaminidase A using BBAE-cellulose.
The two major peaks of hexosaminidase, components A and B,
may be separated on HEAE-cellulose. This method was shown to be
useful for the diagnosis of the G^ gangliosidoses (Young et al.,
1970). The broad peak of hexosaminidase activity, eluting between
components A and B, has been resolved into two peaks of activity
(Price and Dance, 1972). These intermediate forms of hexosamin¬
idase were found mainly in serum and were heat stable. They were
named hexosaminidases I„ and I_ in order of their elution from1 2
BEAE-cellulose.
The BSAE-cellulose batch method was found to be particularly
useful for determining the percentage of Hex-A in different types
of cultured cells. This method gave more satisfactory results
than the original heat inactivation method -using commercial
bovine serum albumin. Bovine serum albumin, which had been
treated to remove hexosaminidase activity before use in the heat
inactivation method, enabled an estimation of Hex-A activity,
closely similar to that determined by the batch method. This
improvement was not attributable to the removal of bovine
hexosaminidase as better results were obtained than when distilled
water was substituted. The DEAE-cellulose batch method was
suitable for quick and simple analyses in laboratories where
several determinations of percentage Hex-A were required but not
sufficient to warrant an automatic system.
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(ii) Percentage hexosaminidase A in different cell types.
It had been observed previously that cultured skin fibro¬
blasts had a higher hexosaminidase activity than cultured
amniotic fluid cells (Sutherland, 1974)• In order to investi¬
gate the possible origin of amniotic fluid cells, Sutherland and
Bain (197<4) had attempted the culture of cells from the urine of
new-born infants. Although the success rate was low, where
growth was achieved, hexosaminidase levels were more like those
of cultured amniotic fluid cells than skin.fibroblasts.
Unfortunately not enough urine cell strains were successfully
cultured in order that the similarity to amniotic fluid cells
and difference from skin fibroblasts could be shown statistically.
Although, in this study, it became clear that the higher specific
activities in fibroblasts were due to Hex-B and that cells
cultured from amniotic fluid and urine consequently had a higher
percentage Hex-A, once again insufficient urine cell strains were
available for statistical differences to be shown.
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(iii)ldentification of hexosaminidase components by isoelectric
/
focusing. '
Isoelectric focusing was a more useful technique than ion
exchange chromatography in that components were concentrated to
a defined isoelectric point and that it was possible to look at
all components at the same time if an ampholyte of sufficiently
wide range was used. It was possible, therefore, to examine
hexosaminidases A and B at the same time and to detect small
differences between components. Hexosaminidases A and B in
cultured cells were similar to those in liver, although liver was
sometimes found to contain an appreciable amount of serum Hex-A,
which had a slightly lower isoelectric point than the tissue form.
Serum, apart from having a different Hex-A, had appreciable 1^
and I^ activities. Pregnancy serum had large amounts of Hex-P,
the isoelectric point of which corresponded to that of Hex-I^.
Previously, Stirling (1972) had suggested that Hex-P was identical
to Hex-I^ on the basis of its elution from BEAE-cellulose.
Neonatal brain had considerable Hex-G activity, so much so that
the combined peak of A and C was shifted to an intermediate
isoelectric point. Assay at pH 4*5 and pH 5*5 showed that there
were two components in this peak. There was no Hex-B in brain
corresponding to that in liver and cultured cells. The broad peak
of activity at pH 6.5-7*5 was probably a combination of 1^ and 1^.
The situation in white blood cells was very complicated. The
hexosaminidase activity, which would have shown up as component A
using EEAE-cellulose, was resolved, at least partially, into five
components. Polymorphonuclear cells appeared to have all five
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components, whereas lymphocytes had three or maybe four. Two of
these were probably tissue and serum Hex-A. It was more difficult
to identify the other three components but peak I was possibly
Hex-S.
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(iv) Hexosaminidase G and its relevance to the G ^ gangliosidoses.
Hex-C was just included in Sephadex G-200 and had an estim¬
ated molecular weight of around 190 000, in agreement with the
findings of Penton et al. (1975)• These workers, however, claimed
that the isoelectric point of Hex-C was pH 5*7 n°t pH 4«80 as
reported here. The molecular weight of hexosaminidases A and B
was reported (Srivastava et al. , 1974) "to be 140 000 determined
by gel filtration and 100 000 by the sedimentation equilibrium
method, less than that of Hex-C.
Hex-C also differed from hexosaminidases A and B in its
greater affinity for the glucosaminide conjugate of methylumbell-
iferone. As the function of components A and B would seem to be
the removal of N-acetyl-galactosamine from G^ ganglioside,
asialo G^ and- globoside, it was not surprising that their
apparent Km was significantly lower for the galactosaminide than
for the glucosaminide. That peak I (Hex-C) had more affinity for
the glucosaminide conjugate suggested that this particular enzyme
was not primarily concerned with the cleavage of N-acetyl-galacto-
saminide linkages. That Hex-C preferred the glucosaminide
substrate and had a more neutral pH optimum was recognised by
other workers (Braidman et al., 1974» Penton et al., 1975)• It
seemed likely, therefore, that Hex-C was genetically unrelated to
hexosaminidases A and B and was not the source of the "unique
subunit of Hex-A.
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(v) Hexosaminidase S and its relationship to hexosaminidases
/
A and B.
The peak of hexosaminidase activity corresponding to Hex-S
had a lower isoelectric point than Hex-C. The half life of Hex-S
was eight minutes, the same as that of Hex-A, under standard
conditions for heat inactivation. Ikonne et al. (1975) quoted
half lives of twenty two minutes and seventeen minutes for
hexosaminidases A and S respectively. Even though the conditions
used by these workers were slightly different, the heat stabilities
of hexosaminidases A and S were very similar. The optimum
activity of Hex-S was at pH 4•5» in agreement with Ikonne et al.
(1975) and Beutler, Kuhl et al. (1975)• This property alone
suggested that component S was a more likely source of the unique
subunit of Hex-A than Hex-C had been.
Hex-S had more affinity for the galactosaminide than for the
glucosaminide conjugate but the apparent K s using both substrates
were higher than those calculated for hexosaminidases A and B.
Although Hex-S preferentially attacked the galactosaminide
substrate, it was not nearly so active towards either substrate
as hexosaminidases A and B. It has been reported (Beutler, Kuhl
et al., 1975) that Hex-S, although precipitated by antiserum
raised against Hex-A, required more antiserum per "unit of enzyme
activity than Hex-A. It was suggested that this was because Hex-S
had less catalytic activity per molecule than Hex-A. The findings
support the view that Hex-S is composed of the subunits different¬
iating Hex-A from Hex-B.
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(b) STUDIES ON HEXOSAMINIDASES IN THE GANGLIOSIDOSES.
RESULTS.
(i) pH profiles of the residual hexosaminidase of cultured skin
fibroblasts from Sandhoff patients.
The hexosaminidase activity of fibroblasts from the two cases
of Sandhoff's disease studied was less than y/o of the control
mean. A pH profile of the residual hexosaminidase activity of
Sandhoff fibroblasts is shown in Figure 20 . With 4-MU-2-acetamido-
2-deoxy-(3-D-glucopyranoside as substrate, the optimum was pH 5-5-6.0
in both cases, but there was a shoulder of activity at pH 4.0-4*5
and in this respect the profiles differed from that of Hex-C










2-deoxy-(3-D-glucopyranoside (2mM) of cultured skin fibroblast
homogenates from two cases of Sandhoff's disease,
case 1 (a) case 2 (a)
pH
pH profiles using 4-me"thylumbelliferyl-2-acetamido-
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The cells had been cultured in the presence of fetal bovine
serum (15%V/v) and it was possible that the shoulder of activity
at pH 4.0-4.5 was attributable to bovine serum hexosaminidase
taken up by the cells. To establish whether this was indeed the
case, a culture of Sandhoff fibroblasts was subculture! into two
culture vessels, one of which was treated in the usual way and
the other, using medium supplemented with heat inactivated fetal
bovine serum, which had been shown to have no hexosaminidase
activity. The cells grown on inactivated serum had a reduced
shoulder at pH 4«0~4«5 compared with the control experiment, but
the profile still did not correspond to Hex-C (Figure 21). It
was concluded that at least some of the activity in the acid
range was intracellular in origin.












FIGURE 21. Comparison of pH profiles using 4-methylumbelliferyl-
2-acetamido-2-deoxy-P-D-glucopyranoside (2mM) of Sandhoff (case 2)
fibroblasts cultured on heat inactivated (a) and untreated
serum (a) .
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substrate, the activity at pH 4.5 relative to that at pH 5*5 was
/




. FIGURE 22. pH profiles using 4-methylumbelliferyl-2-acetamido-
2-deoxy-(3-D-galactopyranoside (0.5mM) of cultured skin fibroblast
homogenates from two cases of Sandhoff's disease,
case 1 (a) case 2 (a)
pH 4.5 and pH 5«5 differed considerably in their relative
activities to the two substrates. When Sandhoff fibroblasts
grown on heat inactivated serum were compared with those grown on
normal serum, there was still activity at pH 4.5 using the galact-
osaminide conjugate as substrate (Figure 2J, page 58). The gluco-
saminidase activity at pH 4«5 was reduced by 61% when Sandhoff
cells were cultured using heat inactivated serum and the galacto-
saminidase activity was reduced by 51%. The increase in activity
at pH 4.5 relative to that at pH 5*5 when using the galactosaminide
conjugate was not, therefore, wholly attributable to hexosaminidase
taken up by the serum. The nature of the residual intracellular
enzyme, active at pH 4«5» was investigated further.
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pH
FIGURE 23 . Comparison of pH profiles using 4-ffiethylumbelliferyl-
2-acetamido-2-deoxy-|3-D-galactopyranoside (0.5mM) of Sandhoff
(case 2) fibroblasts cultured on heat inactivated (a) and untreated
serum (□).
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(ii) Isoelectric focusing of Sandhoff fibroblast homogenates.
There were two major peaks of hexosaminidase activity when
Sandhoff fibroblast homogenates were focused (Figure 24, page 60).
Control fibroblast homogenates, focused at the same time, had two
much larger peaks of activity, corresponding to hexosaminidases
A and B, with isoelectric points at pH 5«5 and- pH 8.2 respectively.
In later experiments, the isoelectric points of hexosaminidases
A and B were somewhat lower. It was not certain what caused this
shift, but it must be taken into account when discussing isoelec¬
tric points. For Sandhoff fibroblasts, the peak corresponding to
Hex-B was broader than for the control and much reduced. The
other peak in Sandhoff fibroblasts had an isoelectric point of
pH 4.80, when assayed at pH 5*5 > the pH optimum of Hex-C (see
page 39). When assayed at pH 4«5> the isoelectric point was
pH 4^65.
Sandhoff fibroblasts, cultured on heat inactivated serum
differed from those cultured on normal serum with respect to their
isoelectric focusing profile (Figure25, page 61 ). The major
difference was in the Hex-B peak. Cells cultured on inactivated
serum had a sharp peak of Hex-B at pH 7-94 whereas, with cells
cultured under control conditions, there was a broad peak of
activity at pH 7-15—7-84> as had been found previously (page 6o).
Under both conditions of culture, there was a recognisable peak of
Hex-A at pH 5.22. This had been observed earlier for this cell
strain (case II). The other cells (case i) studied had no detect¬
able Hex-A, even when cultured on untreated fetal bovine serum.












































































FIGURE 25. Isoelectric focusing in the range pH 3.5-10.0 of
Sandhoff (case 2) fibroblast extracts from cells cultured using
untreated serum and heat inactivated serum .
Fractions were assayed using 4-methylumbelliferyl-2-acetamido-2-
deoxy-(3-D-glucopyranoside (2mM) at pH 4^5«
to be slight differences in the residual hexosaminidases of these
two unrelated patients. The major anodic peak under both
culture conditions had an isoelectric point of pH 4«41 correspon¬
ding to pH 4.65 in earlier experiments.
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(iii)Changes in Sandhoff fibroblast hexosaminidases on storage.
The apparent shift in the optimum of the major residual
hexosaminidase of Sandhoff fibroblasts from pH 5•5-6.0 to pH 4«5>
together with a lowering of isoelectric point was investigated.
The activity of the hexosaminidase of Sandhoff fibroblasts at
pH 4«5 increased relative to that at pH 5*5 after dialysis over¬
night at 4°C against distilled water (Figure 26 , page 63 )> but
this did not occur to the same extent if the extract was dialysed
against 10mM-sodium acetate buffer, pH 5.5* Furthermore, it
became apparent that there was no actual increase in hexosamini¬
dase activity at pH 4«5> but that the change in pH profile was
attributable to a decrease in the activity at pH 5«5-6.0.
pH
FIGURE 26 . Effect on the N-acetyl-f3-D-glu.cosaminid.ase pH profile
of Sandhoff (case 1) fibroblasts when dialysed overnight at 4°G
against (a) distilled water, (b) 10mM-sodium acetate buffer, pH
5«5> compared with (c) extract stored at 4°G overnight.
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(iv) Separation of the hexosaminidases of extracts of G
gangliosidosis fibroblasts by electrophoresis.
Fibroblast hexosaminidases from control and gangliosid¬
osis patients were separated by electrophoresis on "Cellogel" and
visualised by assay at pH 4*5 and pH 5*5 (Figure 27, page 65 ).
Control fibroblast extracts had three bands of enzyme activity,
the fastest of which was low in activity. Sandhoff fibroblasts
had only one band of activity, corresponding to the fastest moving
band in control fibroblasts and, although this was not understood
at the time, seemed to have more activity at pH 4»5 than pH 5«5«
This also corresponded in mobility to Hex-C, prepared from
neonatal brain. Tay-Sachs fibroblasts had two bands of hexosamin¬











FIGURE 27 . "Cellogel" electrophoresis of fibroblasts hexosamini¬
dases from control, Tay-Sachs and Sandhoff patients, visualised
by assay at pH 4.5 and. pH 5*5.
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(v) The residual hexosaminidase in Sandhoff leucocytes.
The pH profile of the hexosaminidase extracted from Sandhoff
leucocytes (case ll) had an optimum of pH 4«5» which was the same
as control extracts, but the peak was much sharper on the acid
pH
pH
FIGURE 28. pH profiles of Sandhoff (case 2) (a) and control (□)
leucocytes using:-
(a) 4-MU_2-acetamido-2-deoxy-P-D-glucopyranoside (2mM).
(b) 4-MU-2-acetamido-2-deoxy-(3-D-galactopyranoside (0.5mM) .
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side. The profiles differed slightly depending on whether the
glucosaminide or the galactosaminide conjugate was used. With
the glucosaminide conjugate, the control extract had a sharper
drop in activity on the neutral side (Figure 28a, page 66 ),
whereas with the galactosaminide conjugate, the Sandhoff extract
had the sharper optimum (Figure 28 b, page 66 ).
The nature of the residual hexosaminidase in Sandhoff
leucocytes was also studied by isoelectric focusing. Using
control leucocytes, earlier studies had indicated the presence of
a number of hexosaminidase components with isoelectric points
around pH 5-0 (page 34)• In this experiment, hexosaminidases
were focused in the range pH 3•5-10*0 and so resolution of these
anodic components was not expected (Figure 29). Sandhoff leuco¬
cytes had a small amount of Hex-B, but the major components had
pH
FIGURE 29. Isoelectric focusing in the range pH 3*5-10.0 of
control and Sandhoff (case 2) leucocytes assayed
using 4-me"thylnmbelliferyl-2-acetamido-2-deoxy-(3-D-glucopyranoside
(2mM) at pH 4*5*
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isoelectric points of pH 4»41 and pH 4«16. These were not
detectable in the control, due to the presence of Hex-A. There
was only a small shoulder of Hex-A activity in Sandhoff leucocytes
(case II). Refocusing of the major Sandhoff peaks in the range
pH 4.0-6.0 gave the two peaks once again, with isoelectric points
pH 4.41 and pH 4.15 respectively, confirming that the latter was
indeed a different hexosaminidase.
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(vi) Diagnosis of Tay-Sachs and. Sandhoff' s disease.
/
Unlike Sandhoff's disease, in which the enzyme deficiency
may be recognised simply by assay of the total hexosaminidase
activity, Tay-Sachs disease is diagnosed by the assay of hexosam¬
inidase component A. Diagnosis may be achieved by a variety of
methods, examples of which are DEAE-cellulose chromatography,
isoelectric focusing, heat inactivation (Figure 30 , page 70 ) and
electrophoresis (Figure 27, page 65 ). It was also noted that
the hexosaminidase pH profile of Tay-Sachs extracts had a flatter
optimum (pH 4»0~4.5) than that of controls with relatively higher
activity at pH 3*0-4.0 (Figure 31 j page 71 )•
Diagnosis of Tay-Sachs and Sandhoff's diseases was usually
undertaken in the first instance on leucocytes as part of a screen
for .lysosomal enzyme deficiencies. If a positive result was
found, this was confirmed on serum and cultured skin fibroblasts.
Table 3 (page 72 ) shows hexosaminidase activities for controls
and for cases and carriers of the gangliosidoses. The percent¬
age Hex-A was calculated from results, obtained using the DEAE-
cellulose batch method. Case II of Sandhoff's disease had hexos¬
aminidase activity which was 8/0 of the control mean in leucocytes
and y/o for serum. Almost all the activity in leucocytes appeared
to be Hex-A or some other component of hexosaminidase which was
bound to DEAE-cellulose at 50mM-NaCl but unbound at 250mM-NaCl.
The percentage Hex-A in Sandhoff serum also appeared to be higher
than in controls.
The Sandhoff heterozygotes tested did not have particularly




time at 50°C (hrs)
"FIGURE 30. Diagnosis of Tay-Sachs disease using cultured skin
fibroblasts by (a) BEAE-cellulose separation of components A and B,




'FIGURE 51 • pH profile of fibroblast extracts from a case of
Tay-Sachs disease (•) and a control (ta) assayed using 4-methyl-
umbelliferyl-2-acetamido-2-deoxy-|3-D-glucopyranoside (2mM).
serum was reduced to about a third of the mean control value.
The percentage Hex-A in both leucocytes and serum of the Sandhoff
heterozygotes was above the control range.
The hexosaminidase activity of Tay-Sachs leucocytes,
although below the control mean, was within the control range.
The activity in Tay-Sachs serum was just below the control range.
It was not possible, however, to distinguish the Tay-Sachs from
controls by assay of total hexosaminidase in leucocytes or serum
with any certainty. The percentage Hex-A in Tay-Sachs leucocytes
and serum was 5% and 2% respectively.
The total hexosaminidase level in leucocytes and serum from
a Tay-Sachs heterozygote was again lower than the control mean,
but well within the control range. Leucocytes from a heterozygote
had 60% Hex-A, well within the control range, but serum from the
same person had only 34% Hex-A, which was below the control range.
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TABLE 5 Hexosaminidase activities in leucocytes and serum of
controls and of carriers and cases of gangliosidosis.
LEUCOCYTES,
nmoles/min per mg protein %A
Controls mean 52.6 66




Sandhoff carriers 1 17.1 85
2 28.9 77
Tay-Sachs carrier 25.4 60
SERA.
nmoles/min per ml %A
Controls mean 22.9 60
n = 9 range 17.4-41.6 45-70
Sandhoff 0.65 87
Tay-Sachs 15 • 5 2
Sandhoff carriers 1 7-6 79
2 7.7 79
Tay-Sachs carrier 19.0 54
-73-
(vii)Antenatal diagnosis for Sandhoff's disease.
During the course of the study, antenatal diagnosis for
Sandhoff's disease was undertaken on two occasions. The two
families involved were those on whom studies were carried out as
described in this section.
The results for each family are set out in Table 4 (page 74 )•
Diagnoses were possible using the amniotic fluid supernatant for
this disease, but it is recommended that assays should also be
carried out on cultured amniotic fluid cells. In each case,
hexosaminidase activity was below control levels, but well above
that of cultured skin fibroblasts from the proband. The import¬
ance of assaying controls cultured at the same time is obvious
from the results, since control levels differed on the two
occasions. This could have been due to unexplained culture
variables.
TABLE4Antenataldiag osisforS ndhoff'sdisease.
Amnioticflu d Test Controls Culturedamnioticfluicells Test Controls Fibroblastsfr mproband Mother'sfibroblasts
Family1Family2 Hexosaminidasectivity(nm les/minperl) 3.065.01 i 5-2011.1 Hexosaminidaseactivity 31.4 57.8 51.5 43.7 1.0(nmoles/minpermgrotein)
16.4 28.3 30.6 33.7 0.9 14.7
Resultsforamnioticfluidwererega dapr liminaryddi g s s




(i) The residual hexosaminidase in Sandhoff fibroblasts.
The major residual hexosaminidase in Sandhoff fibroblasts
was Hex-C. Apart from being more anodic than Hex-A on "Cellogel"
electrophoresis, it also corresponded to Hex-C prepared from
neonatal brain in its neutral pH optimum, its greater affinity
for the glucosaminide conjugate of 4-methylumbelliferone and.
its isoelectric point.
Hex-C was not, however, the only residual hexosaminidase in
Sandhoff fibroblasts. A shoulder of activity at pH 4*0-4.5 was
present, which was not seen in the pH profile of Hex-C, and it
was possible that this was fetal bovine hexosaminidase, taken up
from the tissue culture medium. Some of the activity at pH
4*0-4.5 was indeed shown to be due to contamination by exogenous
hexosaminidases, but activity was present even in cells cultured
in medium supplemented with heat inactivated serum, deficient in
hexosaminidase activity.
The residual activity in the acid range differed from Hex-C
in its relative activities towards the glucosaminide and galact-
osaminide conjugates of 4-me"thylumbelliferone and as with hexos¬
aminidases A and B had more affinity for the galactosaminide
substrate. Isoelectric focusing of Sandhoff fibroblasts revealed
the presence of a small broad band of Hex-B and a major peak with
pi 4«8 when assayed at pH 5«5> and. pi 4.65 when assayed at pH 4«5«
At first this was difficult to explain, especially since the peak
with maximum activity at pH 4*5 was now the major component.
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Vhen the hexosaminidases of Sandhoff fihrohlasts cultured using
inactivated serum were analysed, the peak of activity correspond¬
ing to Hex-B was much sharper. Although other hexosaminidases
may have been taken up by the cells, the most obvious one was
Hex-I^. The isoelectric point of the acid hexosaminidase in
Sandhoff fibroblasts under either condition of culture was now
pH 4-41.
The change of pH optimum of the residual hexosaminidase in
Sandhoff fibroblasts could be explained by the lability of Hex-C.
This was hastened by dialysis against distilled water or during
isoelectric focusing. Dialysis against 10mM-sodium acetate
buffer, pH 5«5> resulted in very little loss of activity,
indicating that Hex-G was particularly labile at low ionic
strengths. Reports that Hex-C is not the major residual hexosam¬
inidase component in Sandhoff's disease (ikonne et al., 1975;
Beutler, Kuhl et al., 1975) might be explained by the lability
of this component.
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(ii) Hexosaminidase S in Sandhoff's disease.
The hexosaminidase of Sandhoff leucocytes differed from
that of cultured skin fibroblasts. In leucocytes there was
little evidence of the presence of Hex-G, except the slightly
greater relative activity on the neutral side when the enzyme
was assayed using the glucosaminide rather than the galactosamin-
ide substrate. The Hex-C could have been lost during preparation.
Isoelectric focusing showed that Sandhoff leucocytes had traces
of Hex-B, but that most of the enzyme was in two peaks of activ¬
ity with isoelectric points of pH 4-41 and. pH 4.1&.
Hex-S, prepared from control human liver, had an isoelectric
point of pH 4.58, which corresponded to the major residual acid
hexosaminidase in Sandhoff fibroblasts and one of the two major
residual hexosaminidases in Sandhoff leucocytes. Wood and
MacDougal (197&) also reported that the major residual hexosamin¬
idase in fibroblasts from a case of infantile Sandhoff's disease
had an isoelectric point of pH 4*40 and that there was very
little of components A and B. A case of juvenile Sandhoff's
disease, also reported in the same paper, had more residual Hex-A
than Hex-S, with Hex-B activity again very low. There did seem
to be some difference in the two cases reported in this thesis.
Case I had a lower overall activity and was apparently totally
deficient in Hex-A, whereas case II had a small shoulder of Hex-A
activity even when cultured in medium supplemented with heat
inactivated serum.
It has been reported (Beutler, Kuhl et al., 1975) that there
are two forms of Hex-S in Sandhoff fibroblasts separable on EEAE-
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cellulose, the major component eluting second. The minor
component, Hex-S', was eluted from BEAE-cellulose at about the
same chloride concentration as Hex-A, but was shown to differ
from Hex-A as it was not precipitated by antibody raised against
Hex-B. Ikonne et al.,(l975)> also using BEAE-cellulose, found
two peaks of hexosaminidase activity in Sandhoff liver. These
peaks were of similar activity and the first corresponded in
position to Hex-A. Similar findings were also reported for plasma.
The peak attributed to Hex-A in Sandhoff liver was probably Hex-S'.
The twin peaks of activity on isoelectric focusing of Sandhoff
leucocyte hexosaminidases, reported in this thesis, were probably
the two hexosaminidase S components. Only one of these components
was detected in Sandhoff fibroblasts with an isoelectric point of
pH 4.41 and it was likely that the major component obscured the
minor. If the double focusing peak in Sandhoff leucocytes corr¬
esponded to that in Sandhoff liver using EGAE-cellulose, the
enzyme component with pi 4»16 was Hex-S'. From the DEAE-cellulose
work, it might have been predicted that the isoelectric point of
Hex-S' was on the neutral side of Hex-S. This does not have to
be the case, however, as previously it has been shown that serum
Hex-A is more anodic (Swallow et al., 1974) and has a lower
isoelectric point (Besley and Broadhead, 197&5 see page 31) than
tissue Hex-A, but is eluted from HEAE-cellulose before the tissue
enzyme (ikonne and Ellis, 1973)• It is possible that Hex-S1
contains a sub-unit of serum Hex-A, whereas Hex-S contains a
subunit of the tissue enzyme. Beutler and Kuhl (1975) suggested
that Hex-S was more anodic than Hex-S', but there was no evidence
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that electrophoresis was on peaks separated on BEAE-cellulose.
Two very close bands of activity were resolved and these were
assigned Hex-S and Hex-S' on the basis of the order of elution of
these components from BEAE-cellulose.
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(iii)Hexosaminidase A in the G ^ gangliosidoses.
The difference in hexosaminidase pH profile between Tay-Sachs
and controls could be predicted from the different profiles of
hexosaminidases A and B. This might be explained by the difference
in stability of hexosaminidases A and B particularly at acid pH
(Saifer and Rosenthal, 1973)» this difference was only found
for a critical pH range around pH 2.8.
The level of hexosaminidase activity in heterozygotes for
the gangliosidoses was dependent on the enzyme source. The
total hexosaminidase activity was of no value in recognising
Tay-Sachs heterozygotes or homozygotes. It had previously been
reported that the total hexosaminidase activity was raised in
Tay-Sachs brain but not in liver and kidney (Sandhoff et al.,
1968; Okada and O'Brien, 19^9) - The hexosaminidase activity was
not found to be raised in Tay-Sachs leucocytes and the serum
level was slightly lower than controls. The hexosaminidase
activity of Sandhoff leucocytes and serum was markedly deficient
and well separated from the lowest control value. Whilst the
leucocyte activities of Sandhoff heterozygotes were below the mean
control value, they were nevertheless in the control range.
However, when serum was used, heterozygous hexosaminidase levels
were well below the control range.
The percentage Hex-A for patients and heterozygotes was
particularly interesting. Very low percentage Hex-A was diagnostic
of Tay-Sachs disease in leucocytes and serum. It was possible to
distinguish the Tay-Sachs heterozygote from controls by measuring
the percentage Hex-A in serum but not in leucocytes. As leucocytes
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were a mixed, population of lymphocytes and PMN, which have
/
different levels of Hex-B (Ellis and Patrick, 197^), this was not
surprising. Although nearly all the hexosaminidase in Sandhoff
leucocytes and most of the activity in Sandhoff serum was classi¬
fied as component A 'using the BEAE-cellulose "batch method,
isoelectric focusing studies showed that this was in fact two
other components of lower isoelectric point, probably components
S and S'. The percentage Hex-A in leucocytes and serum from
Sandhoff heterozygotes was above the control range. These
findings were compatible with the theories and findings of Beutler,
Kuhl et al. (1975) and Beutler and Kuhl (1975)» who proposed that
Hex-B was a homopolymer of (3 subunits, whereas Hex-A was a
heteropolymer of a and 3 subunits and that Hex-S was a source of
the « subunits. As it was proposed that Sandhoff's disease was
attributable to a deficiency of (3 subunits, heterozygotes would
be expected to have half the normal number of 3 subunits and a
normal number of a subunits. A shift to more a,(3 heteropolymers
at the expense of (3 homopolymers would be predicted. Conversely,
Tay-Sachs heterozygotes, with an -underproduction of a subunits,




DEFICIENCY IN POMPE'S DISEASE
-83-
GLYCOGENOSIS TYPE II (POMPE'S DISEASE) AND ITS ASSOCIATED ENZYME
DEFICIENCY.
Glycogen storage diseases were originally categorised into
two types which differed clinically. Whereas type I glycogen
storage disease had mainly liver involvement (vcn Gierke, 1929)>
in type II the heart and muscle were also affected (Pompe, 1932).
Type II glycogen storage disease is also known as Pompe's disease
or generalised glycogenosis on account of the storage of glycogen
in many tissues of the body in this disorder (Hug and Schubert,
1967). It is now recognised that there are a number of other
forms of glycogen storage disease (Howell, 1972).
Hers (1963) reported that the liver of patients who had died
of Pompe's disease was deficient in acid a-glucosidase activity.
Pompe's disease differed from other known glycogen storage
diseases in that the stored glycogen was enclosed by a limiting
membrane (Baudhuin et al., 1964)• Pompe's disease was in fact
the first lysosomal storage disease to be recognised. Glycogen
accumulates within the lysosome owing to the deficiency of the
lysosomal enzyme a-1,4-glucosidase. Whilst glycogen is the sub¬
strate of this enzyme in vivo, less complex glycosides may be
used as substrates in vitro. The substrate usually used in this
thesis was 4-methylumbelliferyl-a-D-glucopyranoside which was
shown (Salafsky and Nadler, 1973b)to be appropriate for the
diagnosis of Pompe's disease. The enzyme will be termed maltase
when the substrate used is maltose and a-glucosidase when fluoro-
genic or chromogenic substrates have been used.
In classical Pompe's disease, patients usually die of cardiac
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failure within one year of birth (Ehlers and Engle, 19&3). A
/
/
milder form of Pompe's disease has been reported in which the
principle clinical finding was muscular weakness, patients
sometimes living to adulthood (Engel, 1970)* The enzymatic
relationship of adult and infantile forms of Pompe's disease is
uncertain. All the cases studied here were of the infantile form
of the disease.
As with the other lysosomal storage disorders, it is
possible to diagnose the disease in utero. Antenatal diagnosis
has been attempted using amniotic fluid, uncultured amniotic
fluid cells and cultured amniotic fluid cells (Nadler and Messina,
1969* Cox et al., 1970; Nadler et al., 1970). Amniotic fluid was
shown to be unreliable (Nadler et al., 1970) since normal levels
of maltase activity at pH 4*0 may be present despite a deficiency
in the cultured amniotic fluid cells. Uncultured amniotic fluid
cells were also found to be unsuitable as very low levels of
a-glucosidase activity can be found even for a normal fetus
(Butterworth et al., 1973) •
The presence of substantial maltase activity in the amniotic
fluid surrounding an affected fetus prompted investigations into
the nature and source of this residual activity (Salafsky and
Nadler, 1971)• It was already known that Pompe kidney had resid¬
ual maltase activity (Mekanik et al., 1966; Steinitz and Rutenberg,
1967). This differed from normal liver maltase with respect to
its pH optimum and response to turanose, an inhibitor of acid
maltase activity. Salafsky and Nadler (1971) reported that
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kidney maltase had an optimum of pH 6.0, was stable at 45°C for
fifteen minutes and was less affected by turanose than the liver
enzyme. The maltase of amniotic fluid also had an optimum of pH
6.0 and was inhibited by turanose to a greater extent than that
of kidney, but much less than that of liver. Amniotic fluid
maltase differed markedly from the kidney enzyme, however, in its
heat stability and was rapidly inactivated at 45°G. On the first
two counts, it was possible that the maltase found in kidney was
the same as that in amniotic fluid. The heat lability of the
amniotic fluid enzyme, however, suggested that this was not the
case. It was possible, however, that some component of the
amniotic fluid rendered the maltase more labile. It was not
stated whether the conditions for heat treatment had been control¬
led. Indeed, it has been shown (Koster et al., 1976) that liver
acid maltase has markedly different heat stability curves when
incubated at pH 4*0 and pH 7«4« A study of a-glucosidase in
Pompe urine revealed that the pH-activity plot of the enzyme was
similar to that of amniotic fluid and kidney (Salafsky and Nadler,
1975a). Urine a-glucosidase from normal adults had a biphasic pH
curve with optima at pH 4*0 and pH 5*5 with much the greater
activity at pH 4*0. Normal infant urine had a broad a-glucosidase
optimum of pH 4.5~5«0 which indicated the presence of more than
one enzyme component.
Although kidney is not usually the tissue of choice in study¬
ing lysosomal enzyme activities, it was possible that the enzyme
found in Pompe kidney might also occur in other tissues particul¬
arly leucocytes and amniotic fluid. This enzyme was studied with
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special emphasis on its behaviour in the presence of turanose.
As maltose and 4-methylumt>elliferyl-a-D-grucopyranoside could
both be used as substrates, the behaviour of a-glucosidase when
the substrates were used in competition was also investigated.
The results of these studies will be presented in the thesis.
With the findings of Nadler et al. (1970) and. Salafsky and
Nadler (1971) that amniotic fluid was unsuitable for the antenat¬
al diagnosis of Pompe's disease, cultured amniotic fluid cells
have become the preferred assay material. This technique cannot
produce such rapid results as time is required to culture suffic¬
ient cells. To overcome this problem, a microtechnique has been
developed (Galjaard et al., 1973)• Using this technique, it was
possible to assay for a-glucosidase activity on as few as seventy
cells grown on plastic foil and to obtain a result in 7_14 days.
However, difficulties were encountered in that two erroneous
diagnoses were made. It was suggested that these difficulties
had arisen from the use of primary cell cultures for the test and
cells of a later passage as controls. Fujimoto et al. (1976)
claimed that the problem was due to the neutral a-glucosidase
having significant activity at pH 4«0. They tackled the problem
by heat-treating samples to remove the more labile neutral enzyme
component. It was doubtful from their results whether any real
problem of interference existed. Their procedure also produced
inconsistent results in that variable amounts of activity at
pH 4.0 were lost and the ratio of activity at pH 4*0 "to that at
pH 6.0 after heat treatment was not constant.
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In leucocytes of Pompe patients, acid maltase has been shown
/
to be deficient (Huijlnget al., 1965; Williams, 1966; Nitowsky
and Grunfeld, 19^7)> although sometimes difficulties have been
encountered in demonstrating this (Koster et al., 1972). They
reported'that leucocytes from cases of the milder variant of
Pompe's disease were not deficient in acid maltase activity and
later this was also shown to be the case in classical Pompe's
disease (Koster et al., 1974)* It would seem that the problem is
due to the method of isolating the leucocytes as the method of
earlier workers preferentially isolated lymphocytes, whereas the
dextran sedimentation technique employed by Koster preferentially
isolated polymorphonuclear cells. Indeed, Koster et al. (1974)
showed this to be the cause of these differences. In view of
this, it was surprising that Seiler et al. (1973) had reported
that for two cases of adult Pompe's disease, the difference
between the enzyme activities in cases and controls was more
pronounced when total leucocytes were used than when lymphocytes
alone were assayed.
Koster et al. (1974) investigated the different components
of maltase in polymorphonuclear leucocytes and lymphocytes to try
to explain the difficulties encountered in the diagnosis of
Pompe's disease. It was shown that when polymorphonuclear cells
were 'used, the maltase activity at pH 4«0 of patients with Pompe'
disease overlapped with the levels of obligate heterozygotes and
when the ratio of the activity at pH 4«0 to that art pH 6.0 was
used, heterozygotes overlapped with both patients and controls.
\
With lymphocytes, there was no overlap of Pompe values at pH 4«0
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with the others, hut it was not possible to distinguish heterozy-
gotes from controls. The ratio of activity at pH 4«0 to that at
pH 6.0 for lymphocytes gave three groups corresponding to
patients, obligate heterozygotes and controls. When clinical
findings suggest that a patient is suffering from Pompe's disease,
a low level on this test would confirm the diagnosis, as carriers
are very unlikely to display clinical symptoms similar to those
of Pompe's disease. This of course would be a completely unaccep¬
table approach if it were applied to antenatal diagnosis, as there
would be no clinical information regarding the fetus in which
heterozygous levels could be expected.
Koster et al. (1976) raised antibody against human liver
acid maltase and found that the maltase activity of lymphocytes
at pH 4.0 was almost completely inhibited by the antibody, but
that of polymorphonuclear cells or dextran isolated leucocytes
had 20/o activity remaining. If polymorphonuclear cells from
patients with Pompe's disease were treated with antibody, no
inhibition occurred. It would seem, therefore, that although
polymorphonuclear cells from Pompe patients have maltase activity
at pH 4.0, the component responsible for the degradation of
glycogen in vivo (acid maltase) is deficient. When glycogen was
used as substrate, activities in both polymorphonuclear cells
and dextran isolated leucocytes of Pompe patients were well
separated from those of controls. It was possible that the
residual maltase activity at pH 4«0 in polymorphonuclear cells
of Pompe patients was related to the residual enzyme in Pompe
kidney. Pompe kidney, however, had considerable residual activity
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towards glycogen as well as maltose (Koster et al., 1976). The
nature of the residual a-glucosidase in kidney, leucocytes and





a-Glucosidase was assayed using 4-methylumbelliferyl-a-D-
glucopyranoside (imM). Substrate (2mM), dissolved in disodium
hydrogen phosphate-citric acid buffer (0.2M/0.1M), pH 4-0
(Mcllvaine, 1921), containing 0.1%V/v Triton X-100 and 0.02%w/v
sodium azide, was mixed with an equal volume of extract. For pH
profiles, one volume of aqueous substrate (4mM) was mixed with
one-volume of double strength buffer and two volumes of extract.
The assay was stopped using 0.1M-sodium carbonate and the fluor¬
escence read as described in the appendix (page 242 ) . When
studying the effect of inhibitors, these were added by using a
reduced volume of extract and making up the volume with inhibitor
solution. The effect of citrate buffer and buffer concentration
was studied using double strength buffers and substrate as for
pH profiles.
Maltase was assayed as follows:-
Maltose in distilled water









Tissue homogenate (1% /v)
Distilled water
After one hour at 37°C, 0.20ml sodium phosphate buffer (0.1M),
pH 7.0, was added and the reaction was stopped by heating at
100°C for 5 minutes. An aliquot (50pl) was taken and the glucose
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released, estimated by the glucose oxidase method as described in
the appendix (page 253 )•
Protein was estimated (Lowry et al., 1951) as described in
the appendix (page 243 ).
Enzyme source and preparation of extract.
(i) Cultured cells.
Amniotic fluid cells and skin fibroblasts were cultivated
as described in the appendix (page 244 )•
(ii) Blood samples.
The dextran sedimentation method was usually used for the
preparation of leucocytes as described in the appendix (page 247 )•
If lymphocytes were required, however, these were prepared using
Ficoll-Paque, also described in the appendix (page 248 ).
(iii)Post-mortem tissues.
Tissues, liver and kidney, were stored at ~40°C until
required.
Homogenates in distilled water were made by sonication using
a "Soniprobe" (Dawe's Instruments) for both tissues and cells.
/W /Tissue homogenates were made up at 1% /v and subsequently diluted
a fifth for the a-glucosidase assay. After sonication, the e
extract was centrifuged at 900g for 5 minutes.
Isoelectric precipitation.
The neutral a-gluccsidase was removed by pretreatment with
acetate buffer, pH 5»0, followed by centrifugation at 900g for
-92-
5 minutes. The final concentration of acetate buffer used for
this precipitation/inactivation step was 10mM for cultured cells,
20mM for leucocytes and 50^ for tissues.
-93-




(i) pH profiles of a-glucosidase in different tissues.
The pH profiles of 4-methylumbelliferyl-a-glucosidase for
cultured amniotic fluid cells and cultured skin fibroblasts,
liver, dextran isolated leucocytes and lymphocytes, kidney and
amniotic fluid are shown in Figure 32 (page 94 )• The charact¬
eristic double peak of activity, present in cultured cells and
liver, was not apparent in leucocytes, kidney and amniotic fluid
and was probably hidden by the presence of an intermediate enzyme
activity. As lymphocytes clearly had an optimum of pH 4»0-4-5>
they must have little or no intermediate enzyme. Cells from
post-mortem kidney were cultured, but these reverted to fibroblast-


























































FIGURE 52 . a-glucosidase pH profiles of (a) cultured skin fibr¬
oblasts (•) and amniotic fluid cells (♦) , (b) liver, (c) dextran
isolated leucocytes (■) and lymphocytes (a), (d) kidney, (e) amni¬
otic fluid and (f) cultured kidney cells.
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(ii) Precipitation and inactivation of a-glucosidase at pH 5.0.
The neutral form of 4-methyTumbelliferyl-a-glucosidase in
cultured cells can be precipitated in the presence of sodium
acetate buffer (lOmM), pH 5*0. The maximum ratio of activity at
pH 4.0 to that at pH 6.0 was attained when preincubation at pH 5-0
was used (Table 5 )• Under these optimal conditions for the
removal of the neutral a-glucosidase, the loss of activity at
pH 4.0 was 8%. When the precipitate was resuspended in sodium
phosphate buffer (lOmM), pH 7.0, not all the activity was recov¬
ered. Precipitation was extremely fast, however, and if the
precipitate was resuspended in buffer quickly, little activity
was lost. Hence some of the activity can be irreversibly inact¬
ivated and not just precipitated.
TABTP 5 Effect of pH treatment on loss of a-glucosidase activity
of cultured skin fibroblasts.
Treatment* % Enzyme a.ctivity
pH 4.0 pH 6.0
Specific activity ratio pH 4.0/6.0
5.5 109 29 5-2
4.0 100 24 5-5
4.5 89 16 4-7
5.0 92 14 5.5
5.5 108 29 5.2
^0 unspun 100 100 0.9
* Cells extracted into water and adjusted to the indicated
PH using one volume 20mM-sodium acetate buffer prior to
centrifugation.
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Precipitation of neutral a-glucosidase in liver and kidney
/
required a buffer of higher ionic strength, as 10mM buffer was
not strong enough to maintain the pH of tissue homogenates at
pH 5.0. Accordingly, homogenates with a final acetate concentra¬
tion of 50mM were prepared, For liver, it was found that some of
the acid a-glucosidase was precipitated when the higher ionic
strength buffer was used (Figure 33a, page 97 )• The removal of
the neutral a-glucosidase, however, was quite effective. The
effect on kidney homogenates was somewhat different (Figure 33b,
page 97 )• Rather more activity was precipitated in the assay
range pH 4*0-5.0 than for liver. The activity, not spun down,
had an optimum at pH 4«5> but there was a shoulder of activity
between pH 5.0 and pH 7.0.
For leucocytes (dextran isolated), a final concentration of
20mM-sodium acetate in the homogenate was used. Precipitation
shifted the optimum to a lower pH and removed a large percentage
of the a-glucosidase activity (Figure 34 > page 97 )• In "the
example, the activity at pH 4.0 was reduced to only one fifth of






















FIGURE 33 . The effect of pretreatment in 5OmM-sodium acetate
buffer, pH 5«0, and centrifugation at 900g for 5 minutes on the
a-glucosidase pH profile of (a) liver and (b) kidney.
(•) total
(■) precipitate, resuspended in 10mM-sodium phosphate, pH 7-0
(a) difference (calculated supernatant)
FIGURE 34 • The effect of precipitation using 20mM-sodium
acetate buffer, pH 5«0, on the pH profile of leucocyte a-gluco¬
sidase.
(•) total
(a) supernatant at pH 5«0
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(iii)lnhibitors of a-glucosidase activity.
The effects of several sugars on the a-glucosidase activity
of kidney were tested. The effects of maltose, turanose, a-methyl-
glucose and sucrose at a concentration of jOnM, on the pH profile
of kidney a-glucosidase are shown in Figure 35 (page 99 )•
Sucrose and a-methyl-glucose had an insignificant effect. As
expected, turanose was a potent inhibitor of kidney a-glucosidase.
Maltose, which is also a substrate for a-glucosidase, was also
found to be an inhibitor when 4-me"thylumbelliferyl-a-D-glucopyran-
oside was used as substrate. Although the maximum inhibition by
turanose was at pH 5.0. it inhibited at all pH values. The peak
of inhibition caused by maltose was sharper and was also optimal
at pH 5.0, but there was a shoulder of inhibition at pH 4*0. Some
activation of the neutral a-glucosidase was noted with a-methyl-
glucose and sucrose, but it was not possible to detect whether
this was the case with turanose and maltose owing to the massive
inhibition of other components in kidney.
The effect of maltose as an inhibitor was investigated in
cultured skin fibroblast and liver homogenates at pH 4*0 "to
determine the effect of the inhibition on the genuine acid a-gluc¬
osidase. In Figure 36 (page 100 ), it can be seen that the
inhibition was almost identical in fibroblast and liver with
30mM maltose inhibiting 60-65% of acid a-glucosidase activity.
The effect 30mM turanose on homogenates of dextran-isolated
leucocytes and cultured skin fibroblasts is shown in Figure 37
(page 100 ). In the presence of inhibitor, the activity in
leucocytes had a neutral optimum of pH 6.0-6.5 with a shoulder at
-99-
FIGUEE 35 • Effect of (a) 30mM-turanose, (b) 30mM-a-methyl-
glucose, (c) 30mM-sucrose and (d) 30mM-maltose on the oc-glucosid-





FIGURE 36 . Effect of increasing concentrations of maltose on
the acid (pH 4.0) a-glucosidase of fibroblasts (# ) and
liver ( ■ ) .
pH pH
FIGURE 37 . Effect of 30mM-turanose on the a-glucosidase pH






pH 4.5-5.0. A plot of the difference between the usual profile
and the turanose inhibited, profile gave a peak of inhibition at
pH 5.0-6.0. The effect of 5OnM-turanose on cultured skin fibro¬
blast a-glucosidase was more marked than for leucocytes. The acid
a-glucosidase was almost totally inhibited and there was some
activation of the neutral component.
The effects of 8mM-maltose on the pH profile of kidney and
liver homogenates highlighted the difference between these two
tissues (Figure 58 ). In liver, the acid a-glucosidase was
FIGURE 38 . Effect of 8mM-maltose on the a-glucosidase pH





inhibited by 30/o, whereas the activity of the neutral peak was
/
/
increased by 50-60%. In kidney, the activity at pH 4«0 was
inhibited by and the neutral activity by 20/o.
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(iv) Combination of pH 5.0 precipitation and maltose inhibition.
A summary of the effects of turanose, maltose and pH 5.0
precipitation is shown in Table 6 . The results for maltose in
conjunction with acid precipitation for liver homogenates are
shown in Figure 39 (page 104 ). The acid component present in
the precipitate was partially inhibited by maltose (8mM), whilst
the neutral component was markedly activated. Plots (Figure 39 »
page 104 ) showing the difference between total activity and prec¬
ipitated activity, with and without maltose, were calculated.
When maltose was not included, all the neutral activity had
apparently been removed and only the acid a-glucosidase remained.
In the presence of 8mM-maltose, however, the acid component was
inhibited, but some activation between pH 6.0 and pH 7«0 occurred.
Thus residual neutral a-glucosidase which had not been precipitated
could be clearly demonstrated by maltose activation. Not surpris-
TABT.F. 6 Summary of the effects of turanose, maltose and pH 5«0
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• FIGURE 39 • Effect of 8mM-maltose on the a-glucosidase pH
profile of liver; (a) the precipitate after pretreatment with





ingly, the results using kidney homogenates were different
(Figure 40 , page 105 )• The precipitated material, as for liver,
had a pH optimum in the neutral region, but a larger shoulder was
found at acid pH. When the precipitate was assayed in the presence
of 8mM-maltose, the a-glucosidase activity at pH 4*0 was reduced
by about 6O/0, whereas the activity at pH 6.0 was barely affected.
The activation of the neutral component, if present, had been
cancelled out by the inhibition of the acid and intermediate comp¬
onents, the activity of which tailed into the neutral range. The
difference plot (Figure 40 , page 105 ) between total activity
-105-





















FIGURE 40 . Effect of 8mM-maltose on the a-glucosidase pH
profile of kidney; (a) the precipitate after pretreatment with





and precipitated activity (ie. calculated supernatant activity)
gave a profile with a peak at pH 4.5 and shoulder at pH 5•5-6.0.
Assay in the presence of maltoso shifted the optimum for this
difference plot to pH 4.0 with a loss of activity of 55% at pH 4.0
and 58% at pH 6.0. Thus a combination of pH 5.0 precipitation
and maltose inhibition almost totally removed the intermediate
and neutral a-glucosidase activities.
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DISCUSSION.
(i) A form of a-glucosidase with pH optimum between the acid
and neutral components of the enzyme.
It was clear that cultured skin fibroblasts and liver homo-
genates had acid and neutral a-glucosidase activities. It had
been noted that the kidney of patients with Pompe's disease was
apparently not deficient in acid a-glucosidase (Mekanik et al.,
1966). Similar results were found for amniotic fluid (Salafsky
and Nadler, 1971) and. dextran isolated leucocytes (Koster et al.,
1974). It was possible that these problems arose because of the
presence of a component of a-glucosidase with a pH optimum between
those of the acid and neutral a-glucosidases, but with considerable
activity at pH 4.0. It was seen quite clearly that the a-glucos¬
idase pH profiles of kidney, leucocytes and amniotic fluid differed
from those of cultured cells and liver. Kidney cells grown in
tissue culture ..Eevertiad to fibroblast type, j so it wfts
clear that this intermediate form of a-glucosidase could not be
maintained in tissue culture.
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(ii) Use of pH 5«0 precipitation for fibroblast extracts.
The precipitation of neutral a-glucosidase from extracts of
cultured skin fibroblasts was very effective and showed that the
contribution of the neutral component in cultured cells to the
activity at pH 4.0 was negligible. It was of interest that other
workers (Fujimoto et al., 1976) considered that the presence of
the neutral enzyme led to problems when undertaking antenatal
diagnosis using cultured amniotic fluid cells. Their solution to
the problem was the differential heat inactivation of the neutral
component. This seemed very unsatisfactory as variable amounts
of activity at pH 4.0 were lost and the ratio of activity at pH
4.0 to that at pH 6.0 was very variable. With pH 5.0 precipita¬
tion, this ratio was remarkably constant. As the neutral a-gluc¬
osidase appeared to have negligible activity at pH 4.0 ana was
considerably more labile than the acid component, the wisdom of
any pretreatment of cultured cell extracts is questionable. When
diagnosis was undertaken by pH profile, the presence of a peak of
activity at pH 6.0 was a useful internal control and showed that
the extract had not been harshly treated.
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(iii)Use of pH 5.0 precipitation for kidney and leucocyte extracts.
The use of pH 5.0 precipitation for dextran isolated leuco¬
cytes and kidney was more useful than for fibroblasts, but not as
effective. The use of buffer of higher ionic strength for tissue
homogenates was necessary, but created problems. The pH profile
of the supernatant was distorted by the pH 5*0 buffer and so this
was not assayed direct, but calculated from the profiles of the
total homogenate and the precipitate. It was realised that some
of the neutral a-glucosidase might be inactivated permanently by
pH 5.0 precipitation, but when all operations were performed
quickly, loss of activity seemed to have been kept to a minimum.
Dialysis to remove the pH 5.0 buffer was not considered, as the
neutral a-glucosidase had been lost on previous occasions when
dialysed.
When used for kidney, pH 5.0 precipitation appeared to be
partially effective in removing the intermediate a-glucosidase
component from solution. An identical experiment with liver
showed that the method also precipitated some of the acid a-gluc¬
osidase when this ionic strength (50mM) was used and it must be
assumed, therefore, that in kidney some of the acid a-glucosidase
was probably precipitated. It was difficult to be sure whether
all the neutral component had been removed, but as was stressed
earlier, this was not important to the activity at pH 4.0.
Experiments with maltose, which will be discussed later (page 110),
suggested that a small amount of neutral component was not preci¬
pitated. The apparent activation by maltose of the enzyme activity
at pH 6.0, calculated to be in the supernatant, was attributed to
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the presence of the neutral component. The pH 5«0 precipitation
method was, therefore, of limited value when working with kidney.
The effectiveness of the removal of most of the a-glucosidase
activity in leucocytes with a marked switch to a more acid pH
optimum by pH 5*0 precipitation suggested that only a small
proportion of the a-glucosidase in dextran isolated leucocytes
was the genuine acid component. It was disappointing that the
hidden level of acid a-glucosidase was so low, but the usefulness
of the precipitation step was exemplified in this instance. These
findings were markedly different from those of Koster et al. (1976)
who found that the percentage of enzyme precipitated from extracts
of dextran isolated leucocytes and polymorphonuclear cells by
antibody specifically raised against acid a-glucosidase was around
&0/o.
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(iv) Inhibitors of g-glucosidase activity.
Turanose inhibited liver a-glucosidase more effectively than
the activity in kidney at pH 4»0 as was also found by Salafsky
and Nadler (1971)• Other suitable inhibitors were sought, which
might perhaps inhibit the enzyme in kidney more than that in liver.
Maltose was found to be suitable for this purpose. This was not
surprising, as it was also a suitable substrate for the enzyme.
It was necessary to lower the concentration of maltose from the
original concentration of JOmM that had been used in order to
lessen the extent of the acid a-glucosidase inhibition, which had
been demonstrated in control liver. An unusual finding was the
stimulation of neutral a-glucosidase activity by both turanose
maltose, which had also been noted for a-methyl glucose and
sucrose. This phenomenon was difficult to explain, but was
possibly due to the stabilisation of this labile enzyme.
It was observed that maltose and pH 5-0 precipitation had
similar, but limited effects on the acid a-glucosidase, both
suppressed the intermediate component and they had opposite effects
on the neutral enzyme. Turanose did not differentiate sufficiently
between the acid and intermediate components. As the removal of
the intermediate component was the prime concern, the joint effects
of pH 5.0 precipitation and maltose inhibition were investigated.
It was found that, although some of the acid a-glucosidase was
lost, when these techniques were used together the intermediate
and neutral components were almost totally removed.
-111-




(i) Diagnosis of Pompe's disease in liver and cultured cells,
Pompe's disease may be diagnosed using certain tissues simply
by the assay of 4-me"tbylxxmbelliferyl-a-E-glucosidase at pH 4«0.
The diagnosis is, however, best illustrated by pH profile. In
Figure 41 (page 112 ), a-glucosidase was assayed in the range
pH 3.0-7.0 using liver, cultured skin fibroblasts and cultured
amniotic fluid cells, showing that cases of Pompe's disease were
easily distinguished from controls. Fibroblasts from some obli¬
gate heterozygotes for Pompe's disease were not so easily distin¬
guishable from cases and extreme care was necessary when under¬
taking antenatal diagnosis. Indeed, amniotic fluid cells from a
low heterozygote for Pompe's disease were encountered (Figure
41 c, page 112 ) during an antenatal diagnosis and the outcome of
the pregnancy was successfully predicted.
FIGURE 41 • Diagnosis of Pompe's disease by the assay of a-gluc-
osidase using (a) liver, (b) cultured skin fibroblasts and
(c) cultured amniotic fluid cells.
(•) control (n) Pompe patient
(a) obligate heterozygote (♦) presumed heterozygote
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(ii) The presence of a-glucosidase activity at pH 4*0 in kidney
and, leucocytes of patients with Pompe's disease.
Although acid a-glucosidase was profoundly deficient in
liver and cultured cells of Pompe patients, there was activity at
pH 4.0 in kidney and dextran isolated leucocytes (Figure 42 ).
FIGURE 42 . a-glucosidase pH profile of (a) kidney and
(b) dextran isolated leucocytes demonstrating the residual





(iii)Effect of buffer concentration on a-glucosidase activity.
When determining the apparent Km of control liver acid :
a-glucosidase and the residual activity of Pompe kidney at pH 4«0,
the concentration of the assay buffer was found to be of import¬
ance. Although the overall activity of control liver acid
a-glucosidase was little affected, the of this enzyme and of
the residual enzyme in Pompe kidney was raised with increased
buffer concentration (Figure 43 5 page 115 )• This was not
simply due to increased ionic strength, as assay in acetate buffers
of increasing concentration did not give rise to similar changes
(Figure 44 j page 116 ). Increasing the concentration of citrate
buffer did not alter the of Pompe kidney a-glucosidase, but
the' of the enzyme in control liver was again raised (Figure
45 > page 117 ). However, the a-glucosidase activity of Pompe
kidney was much reduced in citrate, compared with phosphate-
citrate buffer.
-115-
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FIGURE 45 . Lineweaver-Burk plots of a-glucosidase at pH 4-0
from (a) control liver and. (b) Pompe kidney assayed in phosphate-
citrate buffers of final concentration 0.2M/0.1M (•), 0.1M/0.05M
(■) and 0.05M/0.025M (a).
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PIGURE 44 • Lineweaver-Burk plots of a-glucosidase at pH 4«0
from (a) control liver and (b) Pompe kidney assayed in acetate






FIGURE 45 • Lineweaver-Burk plots of cc-glucosidase at pH 4-0
from (a) control liver and (b) Pompe kidney assayed in citrate
buffers of final concentration 0.2M (•), 0.1M (h) and 0.05M (a).
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Civ) Kinetics of turanose inhibition for control liver and
1/1
Pompe kidney a-glucosidase at pH 4«0»
•J
Plots of ^/i for different substrate concentrations and ^/-
for different turanose concentrations, showed that inhibition was











FIGURE 46 • Lineweaver-Burk plots of a-glucosidase in phosphate-
citrate buffer (0.2M/0.1M final), pH 4*0, (a and b) for different
turanose concentrations 0 (a), 15nM (□) and 50mM (o), and Dixon
plots (c and d) for different substrate concentrations O.JJiM (a),
0.5ieM (■) and 1mM (o) using control liver (a and c) and Pompe
kidney (b and d).
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citrate buffers (Figure 47 ) f°r either control liver or Pompe
kidney.
FIGURE 47 . Lineweaver-Burk plots of a-glucosidase in citrate
buffer (0.2M final), pH 4«0> (a and. b) for different turanose
concentrations 0 (a), 15mM (□) and 30mM (o), and Dixon plots
(c and d) for different substrate concentrations O.JJmM (a) ,
0.5mM (■) and 1mM (®) using control liver (a and c) and Pompe
kidney (b and d).
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(v) Kinetics of 4-mettiy'lumbelliferyl-a-D-glucosidase at pH 4.0
/
in the presence of maltose.
When assayed in the presence of maltose up to a concentration
of 30mM in phosphate-citrate buffer, 4-me"thylumbelliferyl-a-I)-
glucosidase was inhibited competitively when the enzyme source
was control liver and non-competitively when Pompe kidney enzyme
was assayed (Figure 48 )• When citrate buffer was used the
30.0
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FIGURE 48 • Lineweaver-Burk plots of a-glucosidase in phosphate-
citrate buffer (0.2M/0.1M final), pH 4«0, (a and b) for different
maltose concentrations 0 (a), l5mM (□) and 30mM (o), and Dixon
plots (c and d) for different substrate concentrations 0.33mM (A) ,
0.5roK (■) and 1mM (•) using control liver (a and c) and Pompe
kidney (b and d).
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inhibition was competitive for both control liver and Pompe
kidney (Figure 49 )•
When the for control liver and Pompe kidney maltase at
pH 4.0 was determined (Figure 50 , page 122 ), it was found that





































FIGURE 49 • Lineweaver-Burk plots of a-glucosidase in citrate
buffer (0.2M final), pH 4*0, (a and b) for different maltose
concentrations 0 (a), 15mM (□) and 30mM (o), and Dixon plots
(c and d) for different substrate concentrations 0.33mM (a),
0.5mM (n) and 1mM (®) using control liver (a and c) and Pompe











FIGURE 50 . Lineweaver-Burk plots of maltase activity at pH 4*0
for (a) control liver (Km = 10.16) and (b) Pompe kidney (Km = 1.19).
-123-




The inhibition of Pompe kidney a-glucosidase at pH 4.0 by
citrate (0.2M), compared with phosphate-citrate (0.2M/0.1M), was
74% using 1mM substrate and, whereas phosphate-citrate buffer was
a competitive inhibitor, citrate buffer was a non-competitive
inhibitor. The influence of phosphate, adjusted to pH 4-0, on
citrate inhibition of an extract dialysed overnight against 10mM-
sodium citrate, pH 6.0, was investigated. A plot of a-glucosidase
activity against phosphate concentration for different citrate
concentrations showed that only a low phosphate concentration was
required to lift the inhibition (Figure 31 ) and. that, apart from
phosphate (mM)
FIGURE 51 • Reversal of citrate inhibition of a-glucosidase by
phosphate for different citrate concentrations 0.05M (a), 0.125M (■)
and 0.2M (•). Activity in the absence of phosphate at each citrate
concentration v ( ).
o '
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not starting at zero activity, the plot was similar to that of a
plot of enzyme activity against substrate concentration. When
the activity at zero phosphate concentration (v ) was subtracted
from activities with phosphate, a plot similar to that for - was
s
obtained. A double reciprocal plot suggested that phosphate and
citrate were competing for the same site (Figure 52 ).
phosphate
FIGURE 52 . Double reciprocal plot showing competitive reversal
of citrate inhibition of Pompe kidney a-glucosidase by phosphate
at different citrate concentrations 0.05M (a.) , 0.125M (o) and
0.2M (•).
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(vii)Application of the inhibitory effects of turanose, maltose
and citrate to the detection of Pompe's disease in kidney
and the extension of these methods to leucocytes.
The inhibitory effects of 30mM-turanose, 4mM-nialtose and
0.2M-citrate on 4-methylumbelliferyl-a-D-glucosidase activity at
pH 4.0 were quite different for control liver and Pompe kidney
(Table 7 ). Whereas control liver a-glucosidase was affected
most severely by turanose, the enzyme in Pompe kidney was especi¬
ally susceptible to inhibition by maltose and citrate.
A model system was produced by mixing known proportions of
liver and Pompe kidney homogenates to simulate the situation in
control kidney. The percentage inhibition for each inhibitor was
plotted against each of the others (Figure 53 > page 126 ).
TABLE 7 Inhibition (%) of a-glucosidase activity at pH 4»0 of







Control liver 87 18 21





























FIGURE 53 • The relationship of the % inhibition of a-glucosidase
hy turanose (30mM), maltose (4mM) and. citrate (0.2M) in a series






FIGURE 54 • The relationship of the % inhibition of a-glucosidase
by. turanose (50mM), maltose (4mM) and. citrate (0.2M) in homogenates
from eighteen control kidneys (•), a Pompe kidney (a) and control
liver (■).
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The percentage inhibition by turanose was inversely proportional
to that by maltose and. citrate, whereas the effects of maltose
and citrate were directly related. Eighteen control kidney
homogenates were assayed in the presence of these inhibitors and
the results (Figure 54 , page 127 ) were in good agreement with
those of the model system.
When the known percentage of liver acid a-glucosidase in the
model system was plotted against percentage inhibition, straight
line plots were obtained for each of the three inhibitors
(Figure 55 )• Having calculated the best straight line by reg¬
ression, it was possible to estimate the percentage of the acid
a-glucosidase component present in each kidney homogenate by three




FIGURE 55. The relationship of the % inhibition of a-glucosidase
by the three inhibitors to the activity of acid a-glucosidase in
the Pompe kidney-control liver mixtures.
(•) Turanose (50mM) y = 2.5<$x - 125
(■) Maltose (4mM) y = -2.25x + 157
(a) Citrate (0.2M) y = -1.65x + 151
-129-
TABTiR 8 Acid a-glucosidase of kidney: Percentage of total
!
q-glucosidase, estimated using the equations for the three
inhibitors (Figure 55 ; page 128 ).
Sajnple Turanose (50mM) Maltose (4mM) Citrate (0.2M)
1 43 48 40
2 49 43 45
3 51 43 45
4 82 79 77
5 77 79 74
6 46 43 40
7 56 66 59
8 43 43 41
9 46 57 51
10 66 68 64
11 38 43 41
12 54 54 61
13 28 17 19
14 41 34 35
15 79 81 77
16 66 63 67
17 43 28 28
18 51 54 54
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dase activities (nmoles/min per mg protein) for control kidney
(n=18) was 1.87-13.45 with a mean (±SD) of 5.22 (±2.47)> the
activity in Pompe kidney (4«6o) was well within the control range.
The range of acid a-glucosidase activities of these kidneys estim¬
ated from the results in Table 8 (page 129 ) was 1.29-3.75 with
mean (±SD) of 2.51 (±0.6l). The estimated acid a-glucosidase
activity of the Pompe kidney was obviously low (0.05) as it had
been used as zero standard in the derivation of the equations,
but it should be possible to detect the deficiency in kidney from
other cases of Pompe's disease.
Homogenates of eighteen dextran isolated leucocyte prepara¬
tions were also assayed for a-glucosidase activity at pH 4.0 in
the presence of the three inhibitors and the results were similar
to those for kidney (Figure 56 , page 131 ). This suggested that
the a-glucosidase components in leucocytes were the same as those
in kidney and that the equations derived from the model system
could also be applied to leucocytes (Table 9 > page 132 ). The
range of activities (nmoles/min per mg protein) for control leuc¬
ocytes (ru=18) was 0.44-2.67 with a mean (±SD) of 1.44 (±0.60) and
that the acid component estimated from Table 9 (page 132 ) was
0.19-0.92 with mean (±SD) of 0.43 (±0.20). The estimation of
acid a-glucosidase activity would enable the diagnosis of Pompe's
disease in these cells.
Using this method it was possible to show that lymphocytes
were suitable for the diagnosis of Pompe's disease (Figure 56 ,
page 131 ; Table 10 , page 133 )• It was clear from preliminary





FIGURE 56 . The relationship of the % inhibition of a-glu.cosid.ase
by turanose (30mM), maltose (4eM) and citrate (0.2M) in homogenates
of white blood cells.
(■) Lymphocytes; Dextran isolated leucocytes, (•) total homogenates,
(a) supernatant after pH 5.0 precipitation, (♦) precipitate after
pH 5*0 precipitation.
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able to amniotic fluid.
/
/
TABLE 9 Acid a-glucosidase of leucocytes; Percentage of total
g-glucosidase activity, estimated usinff the equations for the
three inhibitors (figure 55 , page 128 ).
Sample Turanose (jOmM) Maltose (4mM) Citrate (0.2M)
1 23 27 27
2 31 14 25
3 18 19 25
4 41 30 32
5 33 32 35
6 31 34 35
7 43 37 41
8 23 17 23
9 13 19 27
10 39 38 42
11 41 39 48
12 31 17 28
13 25 28 35
14 43 26 30
15 46 49 55
16 15 15 25
17 35 37 45
18 34 31 37
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TABLE 10 Purity (%) of acid a-glucosidase in the preparation














B) Lymphocytes 100 107 102
TABLE 11 Inhibition (%) of amniotic fluid a-fflucosidase at
pH 4.0 by maltose, turanose and citrate.
Sample Turanose Maltose Citrate
(50mM) (4mM) (0.2M)
undialysed 24 5 68
dialysed 33 9 77
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(viii)pH 5.0 precipitation as an aid in the diagnosis of Pompe's
disease using dextran isolated leucocytes.
As described previously (page 97 )» the activity of a-gluc-
osidase in dextran isolated leucocytes was massively reduced
particularly at pH 6.0 after precipitation/inactivation at pH 5«0.
In a known case of Pompe's disease, difficulties were encountered
in confirming the diagnosis by assay of a-glucosidase in leuco¬
cytes. After the precipitation step, the activity of the sample
under investigation was clearly separated from that of controls
(f/o of mean) as was that of the proband's mother (38% of mean)
(Figure 57 )•
When the enzyme activity of the pH 5«0 supernatant of control
dextran isolated leucocytes was tested with the three inhibitors,
its behaviour was consistent with a high degree of purity of the
acid a-glucosidase (Table 10 , page 133 > Figure 56. , page 131 ).
FIGURE 57 • a-glucosidase pH profiles of the supernatant after
pH 5.0 precipitation of leucocytes from a typical control (o),
a case of Pompe's disease (□) and a Pompe heterozygote (a).
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Also shown are the results of inhibition studies on the pH 5*0
i
precipitate, resuspended in 10mM-sodium phosphate buffer, pH 7«0.
Although the percentage inhibition using turanose was consistent
with that using maltose, the inhibition using citrate was less
than that predicted from the results using the other two inhibi¬
tors. The results using turanose and maltose were consistent




(i) Diagnosis of Pompe's disease in liver and, cultured cells
and difficulties encountered using kidney and leucocytes.
Using liver or cultured cells it was easy to differentiate
between cases of Pompe's disease and controls by the assay of
4-methylumbelliferyl-a-D-glucosidase activity. When antenatal
diagnosis using cultured amniotic fluid cells is being undertaken,
the importance of first studying the heterozygous levels of enzyme
activity in the family concerned has been clearly demonstrated.
It was not found to be necessary to inactivate the neutral a-gluc-
osidase activity either by heat treatment (Pujimoto et al., 1976)
or by precipitation at pH 5«0 a-s described in this thesis
(page 95 )• Difficulties in the antenatal diagnosis of Pompe's
disease experienced by Niermeijer et al.,(l975) were probably
attributable to a lack of sufficient information on the lower
limits of heterozygous a-glucosidase activity.
Kidney and dextran isolated leucocytes were unsuitable if
diagnosis was attested simply by the assay of a-glucosidase at
pH 4.0 and pH profiles were also of little use in clarifying the
situation. This had been shown previously for acid maltase in
kidney (Mekanik et al., 1966) and in dextran isolated leucocytes
(Koster et al., 1974)• These latter workers found that lympho¬
cytes were suitable for diagnosis by the assay of acid maltase.
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(ii) The effects of inhibitors on control liver and Pompe kidney
g-giucosidase at pH 4»0-
The effect of phosphate-citrate buffer concentration on
a-glucosidase activity, particularly that of Pompe kidney, was
complex. This was not simply due to the ionic strength of the
buffer, as changes in acetate buffer concentration had little
effect. It was not possible to test the effect of phosphate
buffer, as pH 4.0 was outside its buffering range. Although
increasing citrate concentration did not alter the of Pompe
kidney a-glucosidase, citrate was a potent inhibitor of this
enzyme. The slight competitive inhibition of control liver acid
a-glucosidase by phosphate-citrate buffer was attributable to the
citrate component. As citrate alone was a more potent inhibitor
of Pompe kidney a-glucosidase than when phosphate was present,
it would seem that phosphate can lift citrate inhibition. The
reversal of inhibition appeared to be due to competition between
phosphate and citrate for the site at which citrate inhibited
a-glucosidase activity non-competitively. The very low levels of
phosphate required were indicative that phosphate had much more
affinity for this site than citrate. At the concentrations of
phosphate-citrate used for the assay of the enzyme, this site
would be saturated with phosphate, thus nullifying the non-compet¬
itive component of citrate inhibition. Increasing the phosphate-
citrate concentration would then be equivalent to increasing the
effective citrate concentration, with no component of inhibition
at the non-competitive site. Inhibition would, therefore, be
restricted to the hydrolytic site and be competitive.
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Turanose was a competitive inhibitor of control liver and
/
Pompe kidney a-glucosidase at pH 4-0 in either phosphate-citrate
or citrate buffer. When maltose was used as an inhibitor of
4-methylumbelliferyl-a-I)-glucosidase activity, the control liver
enzyme was inhibited competitively as found by De Barsy et al.
(1972), but refuted by Koster and Slee (1977) • For Ponrpe kidney,
when the assay buffer was changed from phosphate-citrate to
citrate, inhibition was changed from non-competitive to competit¬
ive. As the Ponrpe kidney enzyme had more affinity for maltose
than the control liver enzyme, it was surprising that inhibition
of the former was of the non-competitive type (phosphate-citrate
buffers). It has been suggested (de Burlet and Sudaka, 1977)
that the actual function of this kidney enzyme is to transfer one
glucose unit from one maltose molecule to another, producing one
glucose molecule and one molecule of maltotriose. Two sites
would probably be necessary for this transglucosylation reaction
and it is likely that the non-competitive inhibition of Pompe
kidney a-glucosidase is due to the binding of maltose to the non-
hydrolytic site of this enzyme. It would seem that phosphate,
having excluded citrate from the non-competitive inhibition site,
allows maltose to occupy this site, causing non-competitive inhib¬
ition. In the absence of phosphate, citrate would prevent non¬
competitive inhibition by maltose and consequently, the competition
between maltose and 4-methylumbelliferyl-a-D-glucopyranoside for
the hydrolytic site would become apparent.
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(iii)Use of inhibitors in the diagnosis of Pompe's disease in
kidney and. leucocytes.
As the inhibitory effect of maltose was complicated when
a-glucosidase was assayed in citrate buffer, only phosphate-
citrate buffer was used for further inhibition studies with
maltose and turanose. The assay of a-glucosidase in citrate
buffer was included as an extra parameter. Control liver a-gluc¬
osidase was introduced into homogenates of Pompe kidney to enable
study of the inhibitory effects of turanose, maltose and citrate
for known mixtures of control liver and Pompe kidney a-glucosidases.
It was shown that this model represented the situation in control
kidney homogenates and also applied to homogenates of dextran
isolated leucocytes. Using the plots obtained from the model
system, it was possible to estimate the activity of acid a-gluco¬
sidase in kidney and leucocytes, but not in amniotic fluid. The
finding, that the residual a-glucosidase found in kidney, but not
in liver and cultured cells from Pompe patients, was similar- to
that in leucocytes in its response to the three inhibitors, was
surprising as previously it had been reported that Pompe leucocytes
had little activity with glycogen as substrate (Koster et al.,
1974)> whereas considerable activity remained in Pompe kidney
(Koster et al., 1976). Previously, Salafsky and Wadler (1971)
had noted that the maltase activity of amniotic fluid differed
from that of kidney in heat stability.
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Civ) Diagnosis of Pompe's disease in lymphocytes and in leucocytes
after pH 5.0 precipitation.
lymphocyte a-glucosidase responded to inhibitors in the
same way as that of control liver. This was in agreement with
Koster et al. (1974)» who claimed that lymphocytes, but not
dextran isolated leucocytes, were a suitable material for the
detection of Pompe's disease.
Much of the a-glucosidase of dextran isolated leucocytes was
removed by pretreatment at pH 5«0 followed by centrifugation.
The remaining activity assayed at pH 4»0 was almost all acid
a-glucosidase as demonstrated with inhibition studies using
turanose, maltose and citrate. This suggests that pH 5*0
precipitation is of use for the diagnosis of Pompe's disease in
leucocytes. The resuspended pH 5.0 precipitate was inhibited by
turanose and maltose as for Pompe kidney. The results for citrate
were anomalous; the explanation was that the small amount of
phosphate (4mM final in the assay) was sufficient to modify the
inhibitory effect of citrate (0.2M) considerably.
It is concluded that Pompe's disease may be diagnosed using
dextran isolated leucocytes either following pH 5.0 precipitation





DEFICIENCY IN GAUCHER'S DISEASE
-142-
GAUCHER'S DISEASE AMD ITS ASSOCIATED ENZYME DEFICIENCY.
The inherited disorder now known as Gaucher's disease was
first' described by Gaucher (1882). The most common form of the
disease is adult or chronic non-neuronopathic Gaucher's disease
and, as it was the first to be described is known as type 1.
Adult Gaucher's disease is particularly frequent in Jewish
populations. The infantile and juvenile forms, which have neuro¬
logical involvement, are less common. There is overlap in
severity within both the non-neuronopathic form of the disease
and the neuronopathic forms. The safest classification would
seem to be based on whether or not there is neurological involve¬
ment. Of the six cases encountered, five were neurologically
affected. This was probably a reflection of the genetic pool of
Scotland and the age of patients referred to the laboratory for
enzyme s tudies.
Lieb (1924)> investigating the splenomegaly found in Gaucher
patients, isolated large amounts of cerebrosides from spleen. At
first it was thought that this was galactocerebroside but Klenk
and Harle (1930) observed that the cerebroside isolated from
Gaucher spleen differed from galactocerebroside in optical
rotation. Aghion (1934) showed that it was in fact the glucosyl
ceramide and not the galactosyl ceramide which accumulated in
Gaucher spleen. With interest in the lysosomal storage disorders
arising from the discovery that Pompe's disease was due to a
deficiency of lysosomal a-1,4-glucosidase (Hers, 19&3)> it
seemed likely that Gaucher's disease was due to a deficiency of
the enzyme responsible for the catabolism of glucosyl ceramide.
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This was indeed the case and a deficiency of glucosyl ceramide
P-glucosidase activity was demonstrated in Gaucher tissues
(Brady et al., 1965? Patrick, 1965)*
Patrick (19&5) demonstrated the deficiency in Gaucher spleen
by measuring the rate of release of glucose from glucosyl
ceramide, the natural substrate of the enzyme. Using the
artificial substrate, p-nitrophenyl-P-D-glucoside, the p-glucosid-
ase activity of all Gaucher spleens tested was less than 2(f/o of
the control mean (Patrick, 1965)• He also found that liver from
Gaucher patients had J>0/o of the control activity when glucosyl
ceramide was used as substrate, but that the p-nitrophenyl-(3-D-
glucosidase activity was twice the control level! Using another
artificial substrate, 4-niethylumbelliferyl-f3-D-glucopyranoside,
Ockerman (19^8) found one peak of hepatic p-glucosidase on
Sephadex G-150 gel filtration and that this peak was coincident
with that of (3-xylosidase and the final peak of (3-galactosidase.
In Gaucher's disease, P-glucosidase, (3-xylosidase and the final
peak of P-galactosidase were deficient and it was suggested that
all three activities were attributable to the same enzyme protein.
Butterworth et al. (1972) obtained two peaks of p-glucosidase
activity, one of which was in the void volume and the other
It
corresponding to that of Ockerman (1968). Using spleen, Ho (1973)
obtained two peaks of activity, but she had to incubate the homo-
genate in water for one hour at 24°G in order to solubilise the
first peak and so prevent its loss on centrifugation at 100 OOOg.
She also showed that the glucosyl ceramide P-glucosidase was
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associated with the first peak of non-specific P-glucosidase hut
not with the second peak. This was in agreement with earlier
work (Ho and O'Brien, 1971a) demonstrating that the deficiency in
Gaucher's disease was associated with the particulate |3-glucosid-
ase activity and not the soluble. However, Kanfer et al. (1975)
have claimed that both the particulate and soluble (3-glucosidases
may be deficient in Gaucher's disease. The nature of the
deficiency in Gaucher liver using 4-niethylumbelliferyl-(B-I)-gluco-
pyranoside as substrate was investigated in this thesis.
Apart from the apparent inconsistencies outlined above, it
was still likely that one enzyme corresponded to more than one
hydrolase activity. There was the component of (3-glucosidase,
which also had (3-galactosidase and f3-xylosidase activity and was
reported to be deficient in Gaucher's disease, corresponding to
peak III of P-galactosidase on Sephadex G-150 gel filtration
ft t!
(Ockerman, 1968). The three |3-galactosidase peaks of Ockerman
(1968) had pH optima of 4»1> 4*7 and 5«3 respectively. This was
interesting because it had been claimed (O'Brien et al., 1972) that
in G^ gangliosidosis type 1, liver homogenates were deficient in
all P-galactosidases, whereas in type 2 the component with highest
pH optimum remained. The deficiency of neutral (3-galactosidase in
type 1 G gangliosidosis has, however, been questioned (Suzuki
and Suzuki, 1974b). Other data is just as confusing. a-Arabino-
sidase and (3-fucosidase were reported to be deficient in tissues
from patients who had died of G^ gangliosidosis (van Hoof and
f
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Hers, 1968; Hindman and Gotlier, 1972). Liver (3-glucosidase was
shown to be indistinguishable from one of the (3-galactosidase
components by gel filtration, starch gel electrophoresis, heat
stability and its response to the presence of chloride ions
(Ho and O'Brien, 1971b). However, owing to the speed of centrifug-
ation used, they were probably only investigating the soluble
component of (3-glucosidase, Norden et al. (1974) claimed that
another component of (3-galactosidase also had (3-fucosidase and
a-arabinosidase activity, whereas previously Hultberg et al.
(1975) bad reported that Gaucher fibroblasts were deficient in
a-arabinosidase as well as (3-xylosidase and (3-glucosidase. More
recently, Chester et al. (197&) assigned five separate glycosid-
ase activities to the same enzyme molecule. They eluted two
peaks of liver (3-galactosidase from DEAE-cellulose, the first of
which had an optimum of pH 5-5 and also had (3-glucosidase, (3-fuc-
osidase, (3-xylosidase and a-arabinosidase activities. Some of the
a-arabinosidase activity was also associated with peak II. When
the fractions were reassayed after storage at 4°C for four weeks,
there was little diminution of any of the peak I activities. The
3-galactosidase activity in peak II, however, had been totally
lost, whereas about half the a-arabinosidase activity remained.
This was presented as evidence that the acid (3-galactosidases were
not identical with the coincident a-arabinosidase. Furthermore
it was shown using mixed substrate competition experiments, that
peak III of (3-galactosidase on Sephadex G-150 was identical with
3-glucosidase as indeed were 3-xylosidase,.a-arabinosidase and
3-fucosidase. Some of these claims will be looked at in the light
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of the enzyme deficiencies in tissues of patients who died of
G^ gangliosidosis andGaucher's disease.
The enzymic diagnosis of Gaucher's disease has been achieved
using leucocytes (Kampine et al., 1967* Beutler and Kuhl, 1970)
and fibroblasts (Beutler et al., 1970). It was found (Beutler
and Kuhl, 1970) that leucocytes had a double peak of 4-methylum-
belliferyl-|3-D-glucosidase activity with optima at pH 4.0 and
pH 5-3 and that Gaucher leucocytes lacked the peak with optimum,
pH 4.0. Cultured skin fibroblasts had only a single peak of
activity with an optimum of pH 4*0-4.5 (Beutler et al., 1971)•
Ho et al. (1972) reported that fibroblast (3-glucosidase
activity was not linear with dilution and it was proposed that
this was due to the dilution of an important co-factor of the
enzyme. This co-factor was not lost by ultrafiltration and it
was suggested that this might be a protein of molecular weight
greater than 1000. For the assay of (3-glucosidase these workers
used water homogenates and the pH profile for fibroblasts had a
broad optimum of pH 4«5—5•7• This was in marked contrast to the
sharp optimum obtained with saline suspended cells (Beutler et
al., 1971). An interesting finding was the stimulation of (3-gluc¬
osidase activity using 0.02% Triton X-100 (Ho et al., 1972). At
Triton X-100 concentrations lower than 0.02%, no activation
occurred and at higher concentrations the enzyme was inhibited.
When Gaucher fibroblasts were tested, no stimulation occurred.
These results were at variance with those of Beutler et al. (1971)
who found no stimulation of (3-glucosidase activity at concentra-
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tions of Triton X-100 between 0.004% and. 0.25%.
The non-linearity of acid |3-glucosidase on dilution, which
was discussed earlier, suggested that the enzyme activity might
be dependent on more than one constituent. In support of this,
it was found that spleen homogenates from a control and a case of
adult Gaucher's disease, when mixed, had 2-5 times the theoretical
expected enzyme activity (Ho and O'Brien, 1971a). These workers
were also able to separate two factors, namely P and C, both of
which were important for maximum activity. It was proposed that
factor C was the catalytic protein, eluting with peak I |3-gluco-
sidase on Sephadex G-150 gel filtration and that factor P was an
essential activator of factor C. The level of factor P extracted
from adult Gaucher spleen was 10-17 times greater than that from
control spleen and this led to the suggestion that this disease
was attributable to a deficiency of factor G. Ho (1973) went on
to show that glucocerebrosidase activity, as well as the acid
p-glucosidase, was also dependent on the association of factors
P and C. Furthermore, it was shown that the glucocerebrosidase
and (3-glucosidase activities of factor G, solubilised with 0.1%
Triton X-100, could be stimulated using 0.1% sodium taurocholate.
Another important requirement for maximum enzyme activity was
found to be acidic membrane phospholipids, addition of which to
factor C increased activity greatly (Ho and Light, 1975) partic¬
ularly in the presence of factor P. The loss of activity when
factor C was solubilised (Ho and O'Brien, was attributable
to its removal from the cell membrane and consequently its separ¬
ation from these phospholipids. In this thesis the effects of
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Triton X-100, sodium taurocholate and phosphatidylserine were





(3-Glucosidase was assayed using 4-me"thylumbelliferyl-p-D-
glucopyranoside (lmM). The activity at pH 4^0 was used for
diagnostic purposes, but usually diagnosis was undertaken by pH
profile. Column fractions were assayed at pH 5«0. For assays at
a single pH, substrate (2mM), dissolved in acetate buffer (0.2M)
containing 0.02%w/v sodium azide, was mixed with an equal volume
of extract. After incubation at 37°C for a known time (usually
60 minutes), the reaction was stopped by the addition of 0.1M
sodium carbonate and the fluorescence read as described in the
appendix (page 242). For pH profiles, substrate (4jeM) dissolved
in distilled water was added to an equal volume of acetate buffer
(0.4M) containing 0.02%w/v sodium azide and the assay was started
with extract (2 volumes).
In experiments where the assay was carried out in the
presence of sodium taurocholate (0.1%W/v), this was included
when the buffer was made up. Triton X-100 and phosphatidylserine
were included in the assay by reducing the volume of extract and
making up the volume with either distilled water for the control
experiment or additive, e.g. 25yl buffer + 25yl substrate
+ 10yl distilled water or Triton X-100 (ten times final concentr¬
ation) + 40y.l extract.
a-L-Arabinosidase, (3-D-fucosidase, (3-D-galactosidase and
(3-]>-xylosidase were assayed using the appropriate 4-niethyiumbell-
iferyl conjugate, final concentration, 0.5niM. All these hydrolase
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activities were assayed in acetate buffers in the absence of
Triton X-100. The P-xylosidase assay was incubated for six or
seven hours and read immediately after adding alkali, but a
shorter time, usually an hour, was sufficient for the other
hydrolase activities and the reading was stable after the addition
of aLkali. Protein was estimated (lowry et al., 1951) as descri¬
bed in the appendix (page 245).
Enzyme source and preparation of extract.
(i) Cultured cells.
Amniotic fluid cells and skin fibroblasts were cultivated
as described in the appendix (page 244).
(ii) Leucocytes.
Leucocytes were separated from whole blood by differential
sedimentation in dextran as described in the appendix (page 247).
(iii)Post-mortgm tissues.
Tissues, liver and spleen, were stored at ~40°C until
required. ■ >
Cultured cells and leucocytes were usually suspended in
distilled water using a vortex mixer before assay. Such homogen-
ates were not usually sonicated nor centrifuged. Eor special
studies, cells were sometimes suspended in isotonic saline and
dispersed once again using a vortex mixer. Occasionally, saline
suspended cells, particularly leucocytes, were difficult to
disperse owing to clumping and this was overcome by squirting
through a syringe needle a couple of times.
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Tissues were homogenised using a Potter-Elvehjem all glass
hand homogeniser. For gel filtration, homogenates (1C^w/v) were
prepared in elution buffer and centrifuged at 900g for fifteen
minutes. For other studies, homogenates (1 or 2% W/v) were
prepared in the appropriate extraction medium and larger debris
allowed to settle for three minutes. The supernatant was care¬
fully removed for assay. When the effects of different concent¬
rations of EDTA and sodium chloride were tested, the liver was
first homogenised in distilled water and then diluted 1:1 with
double the concentration of EITA or sodium chloride required.
When extracts were sonicated, a "Soniprobe" (Dawe's Instruments)
was used.
Gel filtration.
Ascending gel filtration was carried out at 4°C using a
column (35 x 3cm diam.) of Sephadex G-150 in 10mM-sodium phosphate
elution buffer, pH 6.0, containing 10mM-EDTA and 400mM-NaCl. A
flow rate of 4«5nil/hr was used and 1.5 ml fractions collected for
assay.
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(a) STUDIES ON HUMAN NON-SPECIFIC p-GLUCOSIDASES.
RESUITS.
(i) Separation of P~glucosidase components on Sephadex G-150.
Sephadex G-150 gel filtration of normal human liver extracts,
prepared by homogenisation in a Potter-Elvehjem all glass homogen-
iser followed by low speed centrifugation, usually gave two peaks
of (3-glucosidase activity, the first of which was in the void
volume (Figure 58a, page 153) • On one occasion the second peak
of activity was missing, although there was no suggestion of
Gaucher's disease. It was thought possible that sonication of
the extract might release a soluble component from the void
volume peak. In order to check this, homogenised extracts, which
had either been sonicated or not treated further, were run consec¬
utively on the same column, but it was found that no extra peak
was generated (Figure 58b, page 153)-
Two peaks of (3-glucosidase activity were also obtained with
spleen homogenates, although the second peak was much smaller
relative to the void volume peak; than was usually found for liver
(Figure 59a, page 154)- Homogenates of cultured skin fibroblasts,
cultured amniotic fluid cells and leucocytes were also investigated
by gel filtration (Figures 59b,c,d, page 154)* Although the
activity of these homogenates was low, a recognisable first peak
of activity was detected but there was no„ second peak. It was
possible that such a peak was there, but that its activity fell
below the sensitivity of the assay. Nevertheless, it would seem
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FIGUBE 58 . (a) Sephadex G-150 gel filtration of control liver
0-glucosidase.
00 Comparison of Sephadex G-150 gel filtration
profiles of [3-glucosidase from hand-homogenised ( ) and
sonicated ( ) control liver.
that all or nearly all the (3-glucosidase activity in cultured




FIGURE 59 . Sephadex G-150 gel filtration of (B-glucosidase from
(a) spleen, (b) cultured skin fibroblasts, (c) cultured amniotic
fluid cells and (d) leucocytes.
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(ii) pH profiles of f3-glucosidases from different tissues.
The pH profiles for total water homogenates of liver, spleen,
leucocytes and cultured cells are shown in Figure 60 . Liver
and spleen p-glucosidase profiles were similar with an optimum of
pH 4.5-5.5. Although control fibroblasts had a broad optimum
pH pH
FIGTJEE 60 . pH profiles of f3-glucosidase from water homogenates
of (a) liver, (b) spleen, (c) leucocytes and (d) fibroblasts (two
examples).
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between pH 3*5 and pH 5*0, this could be skewed either way in
/
/
different cell homogenates; two examples with different profiles
are shown in Figure 60d, page 155) • leucocyte j3-glucosidase was
more active at higher pH values and as with fibroblasts seemed to
consist of more than one component.
The pH profiles of the peaks from the Sephadex G-150 column
were investigated to see which part of the total activity they
represented. The results (Figure 61 ) were quite unexpected.
Peaks I and II from liver differed considerably. Peak I pH
profile was fairly symmetrical with a sharp optimum at pH 5*0.
Peak II, on the other hand, had a flattish optimum of pH 5*5-6.0
with very little activity at pH 5*0-4.0. The combined activity
of the two peaks at pH 4*0 was much lower than would have been
predicted using total water homogenates. This difference was
pH
FIGURE 61 . pH profiles of |3-glucosidase for peak I (•) and
peak II (■) from Sephadex G-150 gel filtration of control liver.
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later shown (page 182 ) to be a consequence of the presence of
constituents of the elution buffer in the assay. The single peak
of (B-glucosidase activity obtained by Sephadex G-150 gel filtra¬
tion, for cultured skin fibroblasts and leucocytes (Figure 62 ),
had an optimum at pH 5*0, but in each case the optimum was less
sharp than for liver peak I. Although the profiles for cultured
skin fibroblasts and leucocytes were similar, the optimum skewed
towards the acid side for fibroblasts and towards the neutral for
leucocytes.
FIGURE 62 . pH profile of the peak of fS-glucosidase activity
eluted by Sephadex G-150 gel filtration of (a) cultured skin
fibroblasts and (b) leucocytes.
-158-
(iii)Factors affecting the (3-,n.lucosidase pH profile of cultured
cells.
The effect on the pH profile of (3-glucosidase of assaying in
the presence of Triton X-100 (0.02%v/v) and/or sodium taurocholate
(0.1%W/v) was tested. A typical result is shown in Figore 63 .
In the presence of Triton X-100, the usual broad optimum was
<D
pH pH
FIGURE 63. Comparison of pH profiles of fibroblast (3-glucosidase
assayed (a) with no addition, (b) with 0.1% W/v sodium taurocholate,
(c) with 0.02% V/v Triton X-100 and (d) with 0.02% V/v Triton X-100
/ W /
and 0.1% /v sodium taurocholate.
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transfonned to a sharp peak at pH 5»0« "the example, activation
at pH 5.0-6.0 did occur but this was not always found. The most
dramatic effect was the reduction in activity at acid pH particul¬
arly at pH 5.5. Sodium taurocholate had a similar effect to
Triton X-100, but the new optimum although at pH 5«0 was not as
sharp. A combination of sodium taurocholate and Triton X-100
gave an optimum at pH 5«5 and invariably activated at that pH.
To check that the critical Triton X-100 concentration used
by Ho (1972) had not been missed, the activity of fibroblast
P-glucosidase at pH 4«0 in concentrations of Triton X-100 from
0 to 0.02%v/v was determined. It can be seen in Figure 64 that
20-23% activation was achieved for concentrations between 0.002%
and 0.010% V/v Triton X-100. The activity at a concentration of
Triton X-100 concentration
°/o 7v
FIGURE 64. Effect of Triton X-100 concentration on fibroblast
3-glucosidase activity at pH 4«0.
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used. Any further studies in this section in which Triton X-100
was used were standardised at a concentration of 0.006%V/v.
The role of phosphatidylserine (Ho and Light, 1973; Ho and
Rigby, 1975) in the association of factors P and C raised the
question of what effect this acidic phospholipid would have on
fibroblast (3-glucosidase activity. Once again an unexpected
result was obtained (Figure 65 ). The typical broad pH optimum
for fibroblasts of pH 3«5-5«0 was altered to a sharp optimum at
pH 5.0-5.5 in the presence of 0.15niM phosphatidylserine. In the
example, the activity at pH 4-0 was inhibited by 8&/0 and at pH 5«5
was activated by 46%.
From the diagnostic point of view, it was claimed that
150i
pH
FIGURE 65 . Effect of 0.15idM phosphatidylserine on the pH
profile of fibroblast |3-glucosidase
(•) with no addition (■) with phosphatidylserine
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optimal conditions for assay of (3-glucosidase was with cells
suspended in isotonic saline (Beutler et al., 1971). This was
of interest because it became apparent that the peaks of (3-gluco¬
sidase activity eluted from the Sephadex G-150 column had been
inhibited at acid pH in the presence of sodium chloride (page 185 ).
The effect of sodium chloride on (3-glucosidase was investigated for
cult-urea amniotic fluid cells and skin fibroblasts. The cells were
assayed after preparation by three different methods; cells were
lysed in water, suspended in isotonic saline or lysed with one
volume of water for five minutes and brought back to isotonicity with
one volume of double strength saline. Each of these methods gave
rise to different results (Figure 66 , page 162 ). The specific
activity at pH 4*0 was usually greatest in the case of saline
suspended cells, although the activity at pH 5.0 was greatly
reduced. The overall effect of using saline suspended cells was
that the optimum was sharpened to pH 4.0-4.5« Addition of saline
to lysed cells did not increase the activity at pH 4*0 but severely
inhibited the enzyme at pH 5.0-5.5> whilst the activity at pH 5*0-
6.0 was intermediate between that of saline suspended and water
lysed cells. The effect of sodium chloride seemed to be dependent
to some extent on the integrity of the cell, but inhibition at
pH 5*0-5.5 always occurred.
Another approach was to assay saline suspended cells in the
presence of Triton X-100 (0.006%V/v) and/or sodium taurocholate
(0.1%W/v). It should be noted that the concentration of Triton
X-100 was 0.006%V/v and not 0.02%V/v as used previously. The
results (Figure 67 > page 165 ) once again showed the shift to a
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FIGURE 66 . Effect of sodium chloride on the (3-glucosidase
pH profile of (a) amniotic fluid cells and (b) skin fibroblasts.
(•) cells lysed in distilled water
(■) cells suspended in isotonic saline
(a) cells lysed in distilled water then brought back to














FIGURE 67 . Effect on the (B-glueosi das e pH profile of saline-
suspended cultured cells of 0.006% V/v Triton X-100 (h), 0.1% W/v
sodium taurocholate (a) and 0.006% V/v Triton X-100 with 0.1% W/v
sodium taurocholate (♦) compared with no addition (•).
higher pH optimum in the presence of sodium taurocholate or
Triton X-100. The most dramatic effect was the marked stimulation
of p-glucosidase activity at pH 4«5~5»0 when cells suspended in
isotonic saline were assayed in the presence of 0.006%v/v Triton
X-100.
Figure 68 (page 164) shows the effect of centrifugation and
Figure 69 (page 164) , the effect of centrifugation following
sonication on the (3-glucosidase pH profile of water lysed cells.
Although the three cultures (Figure 68 , page 164 ) differed
slightly in pH profile, in each the total and precipitated activ¬
ities were very similar. A fourth culture was divided into two
halves and one half subjected to sonication before centrifugation,
resulting in a quite different result (Figure 69 , page 164). The
sedimented fraction no longer resembled the total activity in pH
profile. The sonicated total had a different pH profile from the
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unsonicated total and there was some loss of activity at all pH
values. Sonication markedly increased the |3-glucosidase activity
in the supernatant.
pH pH pH
FIGURE 68. Effect of centrifugation at 25000gon the P-glucosi-
dase pH profile of cultured cells (3 examples).
(a) precipitate (a) supernatant (•) total
pH pH
FIGURE 69 . Comparison of pH profiles of cultured cells,
(a) unsonicated and ("b) sonicated prior to centrifugation at
25 OOOg.
(a) precipitate (a) supernatant (•) total
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(iv) The association of P-glucosidase with other glycosidase
activities.
II
It has been claimed. (Ockerman, 1968; Chester et al., 1976)
that p-glucosidase was associated with P-xylosidase, |3-fucosidase
and the small molecular weight components of (3-galactosidase and
a-arabinosidase. The Sephadex G-150 elution profile for normal
human liver is shown in Figure 70 (page 166 ) when assayed for
the five enzymes, [3-galactosidase, (3-xylosidase, (3-fucosidase,
a-arabinosidase and (3-glucosidase. It was observed that each had
activity at or just after the void volume and that all activities
were also detected in the final peak, which eluted just before
haemoglobin. Other components of P-galactosidase, 8-fucosidase
and a-arabinosidase eluted between these two peaks. Using this
crude system, it was possible to separate some of the P-galacto-
sidase, [3-fucosidase and a-arabinosidase components from (3-gluco¬
sidase and |3-xylosidase.
The pH profile for (3-xylosidase in control cultured skin
fibroblasts was very similar to the pattern for (3-glucosidase
and a sharpening of the optimum to pH 4«0-4«5 was observed when
cells were suspended in saline before assay (Figure 71 > page 167 ).
Similarly, the pH profiles of fibroblast p-fucosidase and a-arab¬
inosidase were alike, but differed from (3-glucosidase (Figure 72,
page 167). Unexpectedly, fibroblast (3-galactosidase differed
from both P-fucosidase and a-arabinosidase in pH profile (Figure
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fraction no. (1.5ml)
FIGURE 70. Sephadex G-150 gel filtration of (a) P-D-fucosidase,
(b) (3-D-glucosidase, (c) (3-D-xylosidase, (d) (3-D-galactosidase and
(e) a-L-arabinosidase.
<r
FIGURE 71 . (3-xylosidase pH profile of cultured skin fibroblasts
lysed in distilled water (©) or suspended in saline (h) prior to
assay.
FIGURE 72 . Comparison of the pH profiles of fibroblast
P-D-glucosidase (©) , (3-D-fucosidase (a) and a-L-arabinosidase (a).
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FIGURE 73 . Comparison of the pH profiles of fibroblast (3-D-gal-
actosidase (•), P-d-fucosidase (■) and a-L-arabinosidase (a).
DISCUSSION.
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(i) Gel filtration of |3-glucosidases.
Non-specific (3-glucosidases were separated into two peaks by
!1
Sephadex G-150 gel filtration. Previously, Ockerman (1968) had
detected only one peak of (3-glucosidase activity. The methods
used had been very similar except that the pH of the elution
buffer used here was pH 6.0 not pH 7«6 and the homogenate had not
been centrifuged at 100 OOOg. In view of the known membrane-
bound nature of p-glucosidase, a low speed spin to remove large
particles only was used. Butterworth et al. (1972) also obtained
two peaks of activity having centrifuged homogenates at 25 OOOg.
n
It was likely, therefore, that Ockerman had completely lost one
of the (3-glucosidase peaks in his procedure for homogenate
preparation. Although the method employed here was not ideal
owing to the membrane-bound nature of the enzyme, it was possible
to isolate more than one component. The ineffectiveness of
sonication on the elution profile suggested that the peak I enzyme
eluted in the void volume irrespective of the degree of disruption
of the membrane. Ho (1973) was able to solubilise some of the
membrane-bound (3-glucosidase of spleen by incubation in water for
one hour at 24°C and was able to show that the enzyme, which
was not now removed by centrifugation at 100 OOOg, was eluted
in the void volume. It was also shown that this peak I (3-glucos-
idase corresponded to glucocerebrosidase whereas peak II had no
associated glucocerebrosidase activity. The finding (Ockerman,
1968), that homogenates of Gaucher liver were deficient
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in soluble (3-glucosidase remains puzzling. One liver homogenate
encountered in this study had no peak II activity and this was
also found in previous studies (Butterworth et al., 1972). It is
possible that peak II is a fossil enzyme and now has no function
in which case a deficiency would confer no particular disadvant¬
age. It does not seem likely however that all the Gaucher livers
»!
used by Ockerman were by chance deficient in this enzyme whereas
all the controls had the soluble (3-glucosidase.
The (3-glucosidase activity of cultured cells and leucocytes
was eluted in the void volume which is consistent-with the use of
these cell types in diagnosis (Beutler et al., 1971)•
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(ii) pH profiles of p-glucosidases.
Although the |3-glucosidase activity of leucocytes and cult¬
ured cells was excluded from Sephadex G-150, its pH profile was
different for the two cell types when assayed using water homo-
genates. Whereas leucocytes appeared to "be composed of two
components, the more neutral of which had the greater activity,
the situation in cultured cells was less easy to interpret. In
view of the different profiles obtained for different cell
cultures, it was likely that here again more than one component
was present. The difference between the two appeared to be that
leucocytes had more of the neutral (3-glucosidase, whereas the
predominant component in cultured cells was the acid p-glucosidase.
Changes in the proportion of the acid and neutral components may
give rise to the variations observed in the pH profiles of
cultures.
When the (B-glucosidase pH profiles of cultured cells and
leucocytes, eluted from the Sephadex G-150 column, were investi¬
gated they were very much alike. There was still a suggestion,
however, that cultured cells had more of the acid component than
leucocytes. These profiles were not unlike that of peak I
3-glucosidase from liver which also appeared to have more than
one component. The relative, activities of these components was
also probably responsible for differences in profiles.
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(iii)Effects of Triton X-100, sodium taurocholate and phosphatidyl-
serine on |3-glucosidase activity.
The sensitivity of (3-gTu.cosid.ase to the conditions of assay
almost certainly reflects the importance of an association between
enzyme and membrane for function. It was not possible to obtain
the same effect using Triton X-100 as Ho (1972). Activation at
pH 4.0 was only obtained at concentrations of Triton X-100 below
0.01C^V/v and even at these concentrations, the stimulation was
not as great as had been reported. Nevertheless, activation did
occur using 0.02%V/v Triton X-100 at pH 5*0-6.0 on some occasions.
Similar results were obtained using sodium taurocholate. The
shift in pH optimum which occurred when Triton X-100 or sodium
taurocholate was included in the assay may have been due to a
change in the environment of the enzyme or possibly the differen¬
tial stimulation of one (3-glucosidase component coincident with
the inhibition of another. Similarly, the effect of phosphatidyl-
serine on fibroblast p-glucosidase was either to convert all the
activity to a form with an optimum of pH 5.0-5.5 or to activate
that con^onent with an optimum at pH 5.0-5.5 and, at the same
time, inhibit the acid P-glucosidase.
(iv) Effect of sodium chloride on p-glucosidase activity.
Suspending fibroblasts in isotonic saline often resulted in
activation of (3-glucosidase at pH 4*0-4.5 and- inhibition on either
side of this narrow pH range. The major contributory factor to
this effect was the maintenance of cellular structure. This was
demonstrated when cells were lysed before the addition of sodium
chloride. The effect of Triton X-100 on saline suspended cells
at pH 5.0-3.5 was not unexpected. The release of the enzyme from
the cell left it susceptible to inhibition by sodium chloride.
The activation at pH 4.5-5.0 was more surprising and is unexplain-
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(v) Centrifugation of the (3-glucosidase of cultured, cells.
When cultured cells were lysed in distilled water and centri-
fuged at 25 OOOg, there was no evidence that the small fraction
of the P-glucosidase activity in the supernatant differed
significantly from that in the sediment. This supported the
finding with Sephadex G-150 gel filtration that cultured cells
had no low molecular weight P-giucosidase. If, however, the cell
extract was sonicated before centrifugation, a much larger propor¬
tion of the P-glucosidase was found in the supernatant. Further¬
more, the (3-glucosidase pH profiles of the sediment and the
supernatant were quite different. This again supported the idea
that the variability of profiles was dependent on the environment
of the enzyme when assayed.
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(vi) The common identity of P-glucosidases with other glycosidases.
From the studies comparing several hepatic glycosidase
activities, no evidence was obtained to show that the final peak
of (3-galactosidase on Sephadex G-150 gel filtration was not the
same enzyme molecule as (3-glucosidase, |3-fucosidase, (3-xylosidase
and a-arabinosidase eluting in the same fractions, as proposed
f!
by Ockerman (19^8) . It also became apparent that the other
components of (3-fucosidase and a-arabinosidase were probably
identical to the higher molecular weight (B-galactosidases, in
agreement with Norden et al. (1974) • The (B-xylosidase activity
was coincident with the (3-glucosidase activity in both peaks, so
it was possible that these were identical. It should be stressed,
however, that the first peak was in the void volume where good
resolution of large particles is not possible. Other evidence
for the interrelationship of these glycosidase activities came
from studies of the pH profiles of these enzymes in cultured skin
fibroblasts. Once again it appeared that (3-glucosidase and (3-xyl-
osidase were related and that the responses of (3-fucosidase and
a-arabinosidase were similar. The profile of (3-galactosidase
differed from that of |3-fucosidase and a-arabinosidase and it
was not easy to see the significance of this.
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(b) STUDIES ON g-GLUCOSIDASE IN GAUCHER'S DISEASE.
RESULTS.
(i) Diagnosis of Gaucher's disease using cultured, skin fibroblasts.
All the cases of Gaucher's disease studied here were first
diagnosed using cultured skin fibroblasts with 4_me"thylumbelliferyl-
p-D-glucopyranoside as substrate. As can be seen in Figure 74
some residual activity was present in Gaucher fibroblasts, but
the activity in the three cases was well separated from that in
the control. Also displayed is the (B-glucosidase pH profile for
fibroblasts from a patient diagnosed clinically as adult Gaucher's
disease. In this case, the activity was at the bottom of, but not
separated from the control range. The results of assays at pH 4-0
are displayed in Figure 75 (page 177 )• It can be seen that all
FIGURE 74 • (3-glueosidase pH profiles of cultured skin fibroblasts
from a typical control (o), cases of Gaucher's disease (•) and a
patient diagnosed clinically as adult Gaucher's disease (A).



























FIGURE 75 • Scattergram showing fibroblast (3-glucosidase
activity at pH 4»0 in controls (•) and Gaucher patients (a).
the cases of Gaucher's disease were well separated from the
controls, except the one case of adult Gaucher's disease. No
further work was done on this case and no other cases of adult
Gaucher's disease were encountered apart from cells obtained from
the USA from a patient aged thirty five years with Gaucher's
disease. The (3-glucosidase activity in fibroblasts of this
patient was in the range of the cases with infantile Gaucher's
disease.
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(ii) The 0-glucosidase deficiency in Gaucher liver.
In the course of the study, two of the patients diagnosed
using cultured skin fibroblasts died and tissues were obtained at
autopsy. One patient (K.M.) was of the sub-acute neuronopathic
type and died at four and a half years and the other (R.L.) was
of the acute neuronopathic type and lived for only seven months.
When the first of these (K.M.) died, the 4-me"thylumbelliferyl-(3-
glucosidase activity was determined in liver and, in Figure 76a
(page 179 ), it can be seen that the activity in the Gaucher,
although less than the control, was by no means deficient. The
activity in the spleen of this case was much lower than the
control, although even in this tissue, the residual activity was
about 15% of the control level (Figure 76b, page 179 )-
It was probable that Gaucher liver was deficient in just one
of the components of non-specific 0-glucosidase. As two peaks of
(3-glucosidase activity had been obtained by Sephadex G-150 gel
filtration of control human liver homogenates, this technique was
used for Gaucher liver (R.L.). Once again, however, two peaks of
activity were obtained, eluting in the same fractions as control
liver 0-glucosidases (Figure 77 > page 180 ). Peaks I and II
were also obtained from the liver of the other case of Gaucher's
disease (K.M.). The pH profiles for peaks I and II of both cases
of Gaucher's disease and a control are shown in Figure 78 -
(page 181 ). There was little difference between Gaucher and
control in peak II, but in peak I both Gaucher livers had markedly
reduced activity at pH 4«0.
For each liver, the combined activity at pH 4»0 of "the two
FIGURE 76 . (3-glucosidase pH profile of (a) liver and (b) spleen
of control (O) and Gaucher (K>M.) patient (©).
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fraction no. (1.5ml)
FIGURE 77 • Sephadex G-150 gel filtration of (3-glucosidase from
control ( ) and Gaucher (R.L.) ( ) liver.
separated Sephadex peaks was less than the activity of a water
homogenate. This was particularly noticeable in the two Gaucher
livers. It was suspected that this loss of activity was due to
some component of the elution buffer, in the presence of which
the enzyme had been assayed. When total homogenates of control
and Gaucher liver were prepared in elution buffer, the latter
was now shown to be deficient in (3-glucosidase activity at pH 4«0
(Figure 79 , page 182 ).
The effects of EDTA and sodium chloride, major components of
the elution buffer, on |3-glucosidase activity were investigated.
Extraction in 10mM-EDTA resulted in inhibition at pH 4»0 and
FIGURE 78 . P-glucosidase pH profiles of (a) peak I and
(b) peak II from Sephadex G-150 gel filtration of control (®),
Gaucher (R.L.) (a) and Gaucher (K.M.) (■) liver.
activation at pH 5«5-8.0 for both control and Gaucher liver
(Figure 80a, page 183 ). The effects of different concentrations
of EDTA on activity at pH 4»0 is shown in Figure 81b (page 184 ).
Extraction into 400mM-sodium chloride resulted in almost total
inhibition of (3-glucosidase activity at pH 4«0 for Gaucher liver
and about 60% inhibition of control liver activity (Figure 80b >
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page 18J). The effect of different concentrations of sodium
chloride on enzyme activity at pH 4-0 was investigated (Figure
81a , page 184 ) and. extraction into 200mM-sodium chloride was
optimal for distinguishing between Gaucher and control liver.
When peaks I and II were dialysed against distilled water, the
activity at pH 4-0-4-5 was raised markedly (Figure 82 , page 185 )•
Subsequently, it was shorn that all the non-specific (3-gluco-
sidases present in Gaucher liver could be removed by preincubation
at pH 4.0 in the presence of 50mM-sodium chloride (Figure 83 ,
page 186). After this treatment, the activity was not restored
when the homogenate was assayed at more neutral pH values. It
appeared, therefore, that inhibition at pH 4«0 was a result of
irreversible inactivation. If sodium chloride was removed first
by dialysis, inactivation did not occur to the same extent.
pH
FIGURE 79 • (B-glucosidase pH profiles of control (®) and
Gaucher (R.L.) (a) liver, extracted into 10mM-sodium phosphate




FIGURE 80 . Effect of extraction into (a) 10mM-EIXCA and
(b) 400mM-NaCl on the (3-glucosidase pH profile of control (o,©)
and Gaucher (R.L.) ( A , a) liver. Open symbols indicate no
addition and closed symbols, the addition of EDTA or NaCl.
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EDTA (mM)
FIGURE 81 . Effect of the concentration of (a) NaCl and (b) EDTA
in the extract of control (•) and Gaucher (R.L.) (a) liver on
P-glucosidase activity at pH 4-0.
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FIGUEE 82 . Reversal of the effect of Sephadex G-150 elution
buffer on (a) peak I and (b) peak II of control liver (3-glucosidase
by dialysis against distilled water.
(O) undialysed (•) dialysed
FIGURE 83. Effect of preincubation in 50mM-NaCl at pH 4«0 on
control ( O » •) and Gaucher (R.L.) (a,a) liver. Open symbols
indicate untreated and closed symbols, treated samples.
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(Hi) The activity of other glycosidases in Gaucher's disease.
The common identity of certain components of the glycosidases,
P-galactosidase , P-glucosidase, (3-fucosidase, p-xylosidase and
a-arabinosidase was investigated in controls and cases of G^
gangliosidosis and Gaucher's disease. Gaucher liver had a
similar elution profile to controls for all enzymes assayed
(Figure 84 > page 188 ). As had been observed earlier (Figure 70 ,
page 166 ), the elution profiles of p-galactosidase, p-fucosidase,
and a-arabinosidase were very similar, apart from their relative
activities in the final peak. |3-Glucosidase and P-xylosidase each
had two peaks, coincident with each other and the first and last
peaks of the other three activities assayed.
The elution profile for three of these enzyme activities was
quite different when a liver homogenate from a case of G^ gangli¬
osidosis was eluted from the Sephadex column (Figure 85 , page
189 ). As expected, the non-specific p-galactosidase activity
was very low in this liver, the major peak corresponding to rhe
final peak of control and Gaucher liver. A small fraction of the
activity was eluted with the void volume, but this was less than
1% of the control level for peak I. Similarly, the activities of
P-fucosidase and a-arabinosidase were also deficient in this liver
apart from the final peak. P-Glucosidase and P-xylosidase peaks
were as for control and Gaucher livers.
The peak tubes of peaks I and II P-glucosidase were taken
for pH profiles of all five glycosidases. Samples of the P-galac¬
tosidase activity eluted between the first and last peaks were
taken for pH profiles of P-galactosidase, P-fucosidase and a-arab-
I 1 1 1 I I I
20 30 40 50 60 70 80
fraction no. (1.5ml)
FIGURE 84. Sephadex G-150 gel filtration of (a) |3-D-fucosidase,
(*) (3-D-glucosidase, (c) |3-l>-xylosidase, (d) (3-D-galactosidase and






















20 30 40 50 60 70 80
fraction no. (1.5ml)
FIGURE 85 . Sephadex G-150 gel filtration of (a) |3-D-fu.cosidase,
(b) (3-D-glu.cosidase, (c) (3-D-xylosidase, (d) |3-D-galactosidase and
(e) oc-L-arabinosidase of G^. gangliosidosis liver.
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inosidase for Gaucher and control. There was insufficient of
this intermediate enzyme activity in the case of G gangliosid¬
osis to merit assay. The results for all these profiles are
displayed in Figure 86 (page 191 )• It was observed that (3-gal-
actosidase peak I differed from peaks II and III in pH optimum
and activity at pH J.O-3.5. This was also found for a-arabinosi-
dase and (3-fucosidase, although the profile of |3-fucosidase
peak III was probably somewhat affected by contamination from the
very active peak IV. The pH profile of peak IV was similar for
all the glycosidases assayed, allowing for some contamination by
peak III where present.
The pH profiles for four of the glycosidases in Gaucher and
control fibroblasts are shown in Figure 87 (page 192 ). Gaucher
fibroblasts were deficient in (3-xylosidase but none of the other
glycosidases differed from the control. G^ gangliosidosis fibr¬
oblasts had normal (3-glucosidase and |3-xylosidase activities, but
were deficient in (3-fucosidase and a-aratinosidase as well as
(3-galactosidase .
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FIGURE 86 . pH profiles of (3-glucosidase (o) , p-xylosidase (□) ,
p-galactosidase (•) , |3-fucosidase (a) and oc-arabinosidase (a) of
peaks I-IV from Sephadex G-150 gel filtration of (a) control,
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pH profiles of (a) P-D-xylosidase, (b) P-D-galacto-
p-D-fucosidase and (d) a-L-arabinosidase for
and Gaucher (a) fibroblasts.
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(iv) Factors affecting the pH profile of Gaucher fibroblasts.
The effects of different conditions of assay on the pH
profile of (3-glucosidase, demonstrated in control cells, were
studied in fibroblasts from patients with Gaucher*s disease.
Gaucher fibroblast extracts were assayed in the presence of
Triton X-100 (0.02%V/v), sodium taurocholate (0.1%W/v) or both.
There was no activation at any pH and indeed, for all three comb¬
inations , inhibition occurred (Figure 88 ). Under control condi¬
tions, the optimum was pH 5.0-5.5 and only in the presence of
Triton X-100 was any change characteristic of control cells
(Figure 65 , page 158 ) observed.
The effect of phosphatidylserine on the residual (3-glucosidase
activity of Gaucher fibroblasts (Figure 89 , page 194 ) was
similar, but not as marked as its effect had been on controls
(Figure 65 , page 160 ).
FIGURE 88 . Effect of Triton X-100 (0.02%V/V) (a)> sodium
taurocholate (0.1%W/v) (A.) and Triton X-100 (0.02%V/v) with
sodium taurocholate (0.1%W/v) ($) compared with no addition (@)
on the residual P-glucosidase activity of Gaucher fibroblasts.
3 4 5 6
pH
FIGURE 89 . Effect of phosphatidylserine on the residual
0-glucosidase activity of Gaucher fibroblasts.
(•) 0.15nM phosphatidylserine (h) no addition
Saline suspension had similar effects on the P-glucosidase
activity of Gaucher fibroblasts (Figure 90 , page 195 ) as had
been found for controls (Figure 66 , page 162 ). The sharpening
of the pH optimum, however, was not as marked as in controls and
the residual activity at pH 5-5 > although inhibited, was still












FIGURE 90 . Comparison of the effects of saline suspension (•)




(i) The (3-glucosidase activity of Gaucher liver.
It has been reported (Beutler et al., 1971? Ho et al., 1972)
that cultured skin fibroblasts from patients with adult Gaucher's
were deficient in 4-methylumbelliferyl-(3-glucosidase activity.
In this study, cases of neuronopathic Gaucher's disease were also
found to be deficient, but in one of the two cases of adult
Gaucher's disease investigated only a partial deficiency was
noted.
Liver from two patients with neuronopathic Gaucher's disease
was obtained at autopsy and the 4-me"thylumbelliferyl-(3-glucosidase
activity was not deficient. Similar findings were reported by
Patrick (1965)> who found that the activity of p-nitrophenyl-|3-
glucosidase in Gaucher liver was twice that of controls. However,
the activity of non-specific (3-glucosidase in Gaucher spleen was
much reduced and the results presented here are in agreement with
this finding.
If
Ockcrman (19^8) claimed that Gaucher liver was deficient in
low molecular weight (B-glucosidase, the only peak of activity he
obtained by gel filtration of control liver. However, if low
speed centrifugation was used, it was possible to separate the
(3-glucosidase of control liver into two peaks by Sephadex G-150
If
gel filtration. It would appear, therefore, that Ockerman was
only looking at a part of the total (3-glucosidase activity. When
Gaucher liver was investigated, however, it was found that neither
peak of (3-glucosidase was deficient when assayed at pH 5»0.
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(ii) Identification of the deficiency in Gaucher liver.
When the two peaks from the Sephadex column were taken for
pH profiles, it was shown that Gaucher liver differed from control
liver in peak I only as expected from the reported position of
glucosyl ceramide P-glucosidase (Ho, 1973)• The deficiency in
peak II reported by Ockerman (1968) was more difficult to explain,
but as controls, apparently deficient in peak II, have been
observed (Butterworth et al., 1972), it is possible he was
unlucky in his choice of cases of Gaucher's disease. Another
possibility, however, is that peaks I and II are genetically
linked as with hexosaminidases A and B and that some cases of
Gaucher's disease are deficient in both peaks of (3-glucosidase.
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(iii)Use of sodium chloride in the diagnosis of Gaucher's disease
in liver.
The ease of diagnosis using the separated peaks suggested
that the elution buffer was suppressing interfering (3-glucosidase
components. This was indeed shown to be the case and the activity
at pH 4*0 was reduced in the presence of either 400mM-sodium
chloride or "lOrnM-EDTA. There was also activation at pH 4« 5-6.0
in the presence of EDTA. A similar effect of sodium chloride on
soluble 3-glucosidase and its associated (3-galactosidase activity
had been reported previously (Ho and O'Brien, 1971^) • Although
the activity could be regenerated by dialysis to remove sodium
chloride, the components of non-specific 3-glucosidase which
normally mask the deficiency in Gaucher liver were permanently
inactivated by preincubation of homogenates in 50mM-sodium
chloride at pH 4*0.
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(iv) Activities of other glycosidases 3aid to have common identity
with P-glucosidase in Gaucher tissues.
Studies on the five glycosidases suggested that p-glucosidase
and P-xylosidase activities were attributable to the same enzyme
molecule at least insofar as the enzyme deficiency in Gaucher's
disease was concerned. Similar conclusions were reached by
Ockerman (1968) and Chester et al. (1976). These findings were
II
also in agreement with those of Ockerman (1968) who claimed that
the final peak of (3-galactosidase on Sephadex G-150 also had
3-glucosidase and (3-xylosidase activity. This peak was also
shown to have (3-fucosidase and a-arabinosidase activity. Purified
3-galactosidase has previously been shown to have (3-fucosidase
and a-arabinosidase activities (Norden et al., 1974)• The elution
profile from Sephadex G-150 was very similar for 3-galactosidase,
3-fucosidase and a-arabinosidase, and in G^ gangliosidosis liver
all three activities were absent apart from a little activity in
peak I and the final peak which was unaffected. Gaucher liver was
not deficient in 3-fucosidase as reported by Chester et al. (1976)
nor were Gaucher fibroblasts deficient in a-arabinosidase as
reported by Hultberg et al. (1973)•
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(v) The residual P-glucosidase of Gaucher fibroblasts.
The nature of the residual p-glucosidase in Gaucher fibro¬
blasts was of some interest. It has already been shown that, as
in leucocytes, the (3-glucosidase activity of control fibroblasts
is found only in the void volume of Sephadex G-150. This could
have been due to an inability to detect a low activity of soluble
(3-glucosidase (peak IV) , but as peak IV P-galactosidase was
present in G^ gangliosidosis liver and no activity was detectable
at pH 5.5-6.0 in fibroblasts from this case, the possibility is
unlikely. It was assumed, therefore, that the residual (3-gluco-
sidase in Gaucher fibroblasts would have been eluted in peak I.
As the activity was so low, no attempt was made to establish that
this was indeed the case.
The effect of assay conditions yielded some information as
to the nature of the residual p-glucosidase. In both Gaucher and
control fibroblasts, phosphatidylserine inhibited P-glucosidase
activity at acid pH and activated at more neutral pH. Although
this was not as marked in the case of Gaucher's disease as in the
control, it is reasonable to suggest that the enzyme was the sane
in both. The effects of sodium taurocholate and Triton X-100
were less helpful as the optimum for p-glucosidase in Gaucher
fibroblasts was not dissimilar to that imposed on control fibro¬
blast p-glucosidase by these reagents. There was some evidence
that saline suspension affected the pH profile of the residual
p-glucosidase of Gaucher fibroblasts, but once again, the pH
optimum, biased as it was to a more neutral pH, masked the change.
The response of the pH profile to different conditions suggested
-201-
that (3-glucosidase might exist in more than one interconvertible
/
forms. The residual (3-glucosidase in Gaucher fibroblasts might be
one of these forms, with some activity towards artificial subst¬
rates, but little towards glucosyl ceramide. The deficiency in
Gaucher's disease could be due to an inability to convert this
form to active enzyme. It was interesting that the pH profile
of the residual |3-glucosidase in Gaucher fibroblasts was very
similar to that reported for factor C in the absence of factor P
(Ho and O'Brien, 1971a). However, this residual activity may be
genetically unrelated to the glucocerebrosidase activity, in the
same way as it has been established that hexosaminidase C which





(i) The "use of artificial substrates for the detection of
hydrolase deficiencies in lysosomal storage disorders.
Generally, patients with lysosomal storage disorders have been
found to lack the catalytic activity of a specific degradative
enzyme. Often these enzymes exist in multiple forms that may or
may not be genetically linked. Using artificial substrates, it is
more likely that the multiple forms will be unrelated than when a
natural substrate is used. Nevertheless, as in the case-of.
hexosaminidases A and B, components may be genetically related
but have different natural substrates (Sandhoff et al., 1977)•
In this thesis, three hydrolases have been studied and in each
case neutral as well as acid hydrolase activities were detected.
It is possible that some neutral hydrolases may be transferases
in vivo and it may be significant that neutral a-mannosidase is
activated by cobalt (Phillips et al., 1974), which is also an
activator of galactosyl transferase activity (Butterworth, 1974)•
The results suggested that neutral and acid activities were
unrelated and methods were developed for the removal of activities
which hinder the diagnosis of storage disorders using low specifi¬
city artificial substrates.
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(ii) Interrelationships of different enz:^me components,
/
Although patients with Tay-Sachs disease were found
(Svermerholm, 1962) to store G^ ganglioside, a lipid which could
he degraded using calf brain N-acetyl-(3-D-hexosaminidase (Frohwein
and Gatt, 1967)* "they were found not to have a total deficiency of
N-acetyl-p-D-hexosaminidase activity (Sandhoff et al., 1968).
It was eventually found (Okada and O'Brien, 19^9)» however, that
Tay-Sachs patients were deficient in one particular hexosaminidase
component, namely Hex-A. The panethnic form of G^ gangliosidosis,
Sandhoff's disease, which accounts for one third of cases, was
recognised as a distinct variant with a total deficiency of
N-acetyl-P-D-hexosaminidase by Sandhoff et al. (1968). It is
possible that other diseases may be due to a deficiency of one
component only. Indeed, it would seem that patients with
Niemann-Pick disease type C may be deficient in certain but not
all components of sphingomyelinase (Callahan et al., 1974; 1975?
Besley, 1977).
It has been claimed that infantile Pompe's disease has
reduced neutral maltase activity in heart and muscle (Angelini and
Engel, 1972) suggesting that the acid and neutral components are
under common regulatory control (Angelini and Engel, 1973)> but,
in work presented in this thesis (page 112), neutral a-glueosidase
was not significantly reduced in Pompe fibroblasts. It is possible,
however, that stored glycogen may inhibit neutral a-glucosidase
activity similarly to the inhibition of (3-galactosidase by glycos-
aminoglycans in Hunter and Hurler syndromes (Kint, 1973; 1974)-
Similarly, although the glucocerebrosidase activity, shown
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to be deficient in Gaucher's disease (Brady et al., 1965; Patrick,
1965) is associated with the particulate non-specific |3-glucosidase
activity (Ho, 1975)> Gaucher patients have been reported (Ockerman,
1968; Kanfer et al., 1975) who were also deficient in soluble
3-glucosidase activity. It has been suggested (Peters et al.,
1975) that the particulate glucocerebrosidase and soluble
non-specific (3-glucosidase are genetically related. Neither of
the cases encountered in this study, one infantile and one
juvenile, was deficient in low molecular weight (soluble) (B-gluc-
osidase in liver (page 180). Control livers have, however, been
shown to lack soluble (3-glucosidase activity (Butterworth et al.,
1972; Cheetham et al., 1978) and it is possible that a deficiency
of this enzyme has no clinical significance.
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(iii)The interrelationships of hexosaminidase components.
It was clear from the different storage materials (Sandhoff
et al., 1971) in Tay-Sachs and Sandhoff's diseases, that hexosam¬
inidases A and B had different substrate specificities and it
would appear that only Hex-A can attack the sialated form of
stored lipid, G^> ganglioside (Sandhoff et al., 1977)• As
hexosaminidases B, 1^ and 1^ are all present in Tay-Sachs tissues
(Young et al., 1970), these components are probably closely
related. Similarly, the serum and tissue forms of Hex-A are both
deficient in Tay-Sachs disease (Okada and O'Brien, 19^9) suggesting
that these too are closely linked.
In I--cell disease, the activity of certain acid hydrolases is
raised in serum (Viesmann et al. , 1971) in culture medium in
which the I-cell fibroblasts have been grown (Wiesmann and
Herschkowitz, 1974) i "the activity of these enzymes in fibroblast
extracts, however, is decreased (Leroy et al., 1972). It was prop¬
osed (Hickman and Neufeld, 1972) that in I-cell disease the recog¬
nition site enabling certain hydrolases to be taken up into lyso-
somes is altered. It was noted, however, that I-cell fibroblasts
released only serum forms of hydrolases into the medium, whereas
control cells had both serum and tissue forms in the surrounding
medium (Ellis, Willcox and Patrick, 1975)j suggesting that the
deficiency was in the biosynthetic pathway of tissue forms. It is
likely that, if tissue and extracellular forms are derived from
the same biosynthetic pathway, the activity of extracellular forms
will be raised in I-cell disease. This is so and as serum and
tissue forms of Hex-A are deficient in Tay-Sachs disease, whereas
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components B, 1^ and. are retained, it is likely that tissue
Hex-A and serum Hex-A have a common precursor as have hexosamini¬
dases B, 1^ and I^.
It would appear that Hex-S contains the unique subunit of
tissue Hex-A (Beutler and Kuhl, 1975)• Another component, Hex-S',
was reported by Beutler, Kuhl et al. (1975) to elute from EEAE-
cellulose before Hex-S. In this study, however, the component
corresponding to Hex-S1 had a lower isoelectric point than Hex-S
(pages 67, 78). The relationship of Hex-S1 to Hex-S closely para¬
lleled that of serum Hex-A to tissue Hex-A using these two techniques
(ikonne and Ellis, 1975 > this thesis pages 31, 32). It would seem
likely, therefore, that just as Hex-S provides the unique subunit
differentiating Hex-A from Hex-B, Hex-S' is the source of the unique
subunit of serum Hex-A. Similarly, there may be two forms of
Hex-B subunit, formed from a common precursor which may explain
the relationship of Hex-B to components 1^ and IHex-B may
contain all tissue subunits, Hex-I^ half tissue and half serum
subunits, and Hex-I^ all serum subunits. If there were tissue
and serum forms of a. and (3 subunits, aggregating as half molecules,
four forms of Hex-A would be predicted, unless it were postulated
that serum and tissue forms of a subunit could only form serum
Hex-A and tissue Hex-A respectively with one form of (3 subunit.
It is possible, however, that more than two forms of Hex-A do
exist as demonstrated by sucrose gradient isoelectric focusing of
leucocytes (page 34) and the multiple bands of hexosaminidase
obtained by gel isoelectric focusing of serum (Hayase and
Kritchevsky, 1975). The proposal of Srivastava et al. (1976) that
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hexosaminidases B, 1^, IA, S1 and S are all hexamers and
constituted (3^, P^a^, P^a2> P^a^2a4 ^ia5 resPec"tively does
not allow the presence of hexosaminidases 1^ and in Tay-Sachs
disease (Young et al., 1970) noP "the residual Hex-S activity in
Sandhoff's disease (Beutler, Kuhl et al., 1975; Ikonne et al., 1975)•
Other workers (Geiger and Arnon, 1976? Lee and Yoshida, 197^;
Beutler et al., 197&) claim that hexosaminidases A and B are
tetramers, but Srivastava (Wiktorowicz et al., 1977) has recently
reiterated his contention that the hexosaminidase components are
hexamers. It is proposed in this thesis that the various compon¬
ents of hexosaminidase are combinations of tissue a, p and serum
a* , P' subunits as summarised below. Components I-Y are as
described on pages 35 and 34•















Hex-C was present in both Tay-Sachs and Sandhoff's disease
(page 65), as also found by Penton et al. (1975)• This, as well
as its more neutral pH optimum (page 39) and greater affinity for
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the glueosaminidase substrate (page 40), suggested that it was
not related to the other hexosaminidases and is, therefore, not
discussed here.
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(iv) The a-glucosidase components.
/
Pour major a-glucosidase components were encountered in this
study. Acid and neutral components were found in liver, cultured
cells and lymphocytes (page 94)5 hut the latter of the two compon¬
ents was not extensively studied as it had little activity at
pH 4.0 and so did not interfere with the diagnosis of Pompe's
disease (page 112) as had been feared (Pujimoto et al., 1976).
Two other components, one found in kidney and leucocytes (pages
94» 113) and the other in amniotic fluid (page 94)> which have
neutral pH optima but considerable activity at pH 4^0 are
designated intermediate components to differentiate them from the
other two forms. It was confirmed (page 113) that the intermediate
component was retained in kidney (Steinitz and Hutenberg, 1967)
and leucocytes (Koster et al., 1972) of patients with Pompe's
disease. Using inhibitors, it was established that the intermed¬
iate components of kidney and leucocytes were similar (pages 125-
151), but differed from that of amniotic fluid (page 133)• It had
previously been shown that kidney and amniotic fluid had different
maltase components (Salafsky and Nadler, 1971)> but other reports
(Koster et al., 1974» Koster et al. , 1976) using glycogen as
substrate suggest that kidney and leucocyte components also differ.
Amniotic fluid a-glucosidase may be an altered form of the kidney
enzyme with a different response to inhibitors.
Kidney a-glucosidase has a greater affinity for maltose than
the acid a-glucosidase of liver (page 122) , but its 4-meIhylumbell-
iferyl-a-D-glucosidase activity was inhibited non-competitively
(phosphate-citrate buffers) by maltose (page 120). It would seem,
-211-
therefore, that this enzyme has two active sites with affinity for
maltose, consistent with an in vivo transglucosylase function as
proposed by de Burlet and Sudaka (1977)• That this enzyme is
found in kidney but not in liver suggests that it is possibly
involved in transport mechanisms. Also of interest is the presence
of this enzyme in polymorphonuclear cells, but absence from
lymphocytes (page 133) > indicating that the latter are more suit¬
able for the diagnosis of Pompe's disease.
Only one hydrolytic site for maltose and 4-methyiumbelliferyl-
a-D-glucopyranoside was detected for liver acid a-glucosidase
(pages 120,121) in agreement with de Barsy et al. (1972), but not
with Koster and Slee (1977)> who claimed that the acid a-glucosidase
had two sites, one of which bound glycogen and maltose, and the
other, 4-niethylumbelliferyl-a-D-glucopyranoside. This finding
would cast doubts on the usefulness of the 4-methylumbelliferyl
conjugate as a substrate. The fluorogenic substrate, however,
could be used for diagnosis, especially using liver and cultured
cells (page 112) and was much more sensitive than maltose as was
also found by Salafsky and Nadler (1973*0 •
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(v) The 0-glucosidase component deficient in Gaucher's disease.
Liver (3-glucosidase had soluble and particulate components,
which were separable by Sephadex G-150 gel filtration (page 155)•
The activity of the soluble component of spleen was much less than
that of liver (page 154)* In "the two Gaucher livers studied, the
0-glucosidase deficiency was detected in peak I (page 181) as
predicted from studies using glucocerebroside as substrate (Ho,
1975)• Apart from the component deficient in Gaucher's disease,
there was another component in peak I (page 181), probably corres¬
ponding to the residual particulate enzyme reported by Owada et al.
(1977) in certain Gaucher patients. The 0-glucosidase activity
of leucocytes and fibroblasts was eluted in the void volume of
Sephadex G-150, no peak II being detected. Leucocytes had a
considerable amount of the more neutral 0-glucosidase activity,
which was presumably the component associated with peak I and
retained in Gaucher's disease, but there was little of this in
fibroblasts. It is possible that the residual activity in Gaucher
fibroblasts is an altered form of. acid 0-glucosidase as suggested
by Turner et al. (1977)- Interestingly, the pH profile of this
component (page 176) was similar to that of the catalytic protein,
factor C (Ho and O'Brien, 1971a).
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(vi) Clinical heterogeneity of Gaucher's disease.
/
The markedly different clinical courses of the neuronopathic
and non-neuronopathic forms of Gaucher's disease are not as yet
satisfactorily explained. The liver of the case of infantile
Gaucher's disease (R.L.) had non-specific |3-glucosidase activity
in both peaks I and II (page 180), so it was not possible to
relate the severity of the disease in this patient to the activity
of soluble and particulate fractions as attempted by Kanfer et al.
(1975)• Of two cases of adult Gaucher's disease investigated
(pages 176,177), one had fibroblast P-glucosidase activity just
below the control range, but, in the other case, activity was in
the same range as that of infantile and juvenile patients. It was
reported that in one case of adult Gaucher's disease, factor C was
deficient in spleen (Ho and O'Brien, 1971a), whereas the activity
of factor P, the effector protein, was raised. However, the
determination of the activities of factors P and C in several cases
of Gaucher's disease showed no clear difference between adult and
infantile cases (Ho et al., 1977), three adult patients having no
factor C and raised factor P in common with one infantile patient,
but with another infantile patient having no factor P.
Interestingly, the activity of glucocerebrosidase is not
markedly reduced in I-cell fibroblasts (Wenger et al., 1976) , a
property setting it apart from many other acid hydrolases and so
this enzyme may have a secondary function in general lysosomal
organisation. Niemann-Pick disease also exists in neurological
and non-neurological forms (Frederickson and Sloan, 1972), hut the
enzyme associated with this disorder, sphingomyelinase, does have
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low activity in I-cell fibroblasts (Wenger et al., 197^). It has
been found (Peters et al., 1977)> however, that sphingomyelin
inhibits (3-glucosidase activity and this may account for the
storage of glucosyl ceramide in Niemann-Pick disease (Harzer et al.,
1977) and. might explain certain similarities between Gaucher1s
disease and Niemann-Pick disease. The difference between neurono-
pathic and non-neuronopathic Gaucher's disease is, however, more
likely to be explained by a secondary effect than by some slight
difference in the amount of residual activity.
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(vii)Multiple specificity of (3-glucosidase components.
When investigating the enzyme deficiency in Gaucher liver,
Ockerman (1968) made use of the multiple specificity of soluble
(3-glucosidase. As well as having |3-glucosidase activity, this to
component also had (3-galactosidase and (3-xylosidase activities.
It was also reported that a-arabinosidase was deficient in Gaucher
fibroblasts (Hultberg et al. , 1973) > as was (B-fucosidase in
Gaucher liver (Chester et al., 1976) .
The results presented in this thesis are at variance with
some of these claims. Using liver from cases of Gaucher's disease,
G gangliosidosis and controls, it was found that all components
of P-galaa:osidase, separated by Sephadex G-150 gel filtration
had a-arabinosidase and (B-fucosidase activity (page 166). All
except the final (3-galactosidase peak was deficient in G gangli-
ii I
osidosis liver (page 189) j (3-glucosidase and (3-xylosidase activities
were normal. The pH profile of (3-galactosidase from control cult¬
ured skin fibroblasts (page 168) , however, differed from those of
a-arabinosidase and (3-fucosidase, which were identical. A defici¬
ency of a-arabinosidase and (3-fucosidase in G gangliosidosis
had previously been reported by van Hoof and Hers (1968) and
Hindman and Cotlier (1972).
Liver (3-glucosidase activity was eluted from Sephadex G-150
in two peaks, one of which was just before the first peak of
3-galactosidase and the other, coincident with the final peak of
(3-galactosidase (page 166) . The elution pattern of (3-xylosidase
coincided with that of P-glucosidase (pages 166, 188, 189),
consistent with the structural similarity of the two substrates
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(see the appendix, page 254)• In Gaucher fibroblasts, the defici-
/
ency of 3-xylosidase was more pronounced than that of (3-glucosidase,
but the activities of (3-galactosidase, P-fucosidase and a-arabino-
sidase were normal (page 192). The multiple specificity of soluble
P-glucosidase provides little information as to its natural funct¬
ion. It has been suggested (Chester et al., 1976) that this
might be an "obsolete evolutionary remnant" with no present day
function, consistent with its absence from some control livers
(Butterworth et al., 1972; Cheetham et al., 1978). There was no
evidence for the suggested enzymatic relationship (Chester et al.,
1976) between Gaucher's disease and G gangliosidosis.
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(viii)Methods for the removal of interfering components.
Methods were developed for the assay of specific enzyme
components in tissues where other components were also found.
At the outset of this work, Hex-A was assayed ty heat (O'Brien
et al., 1970) or pH (Saifer and Perle, 1974) inactivation, BEAE-
cellulose chromatography (Young et al., 1970) or electrophoresis
(Robinson and Stirling, 1968). The most useful quantitative method
was found to be the DEAE-cellulose batch method (Dance et al.,
1970), which gave results (page 27) closely in agreement with
those by the DEAE-cellulose column method. The heat method under¬
estimated the activity of Hex-A (page 27), probably due to some
conversion of Hex-A to Hex-B (Tallman et al., 1974)> but still
reliably detected Tay-Sachs disease (page 70).
Techniques developed for the removal of non-specific a-gluco-
sidases and P-glucosidases were by inactivation. Neutral and
intermediate a-glucosidases were found to be susceptible to prec-
ipitation/inactivation in acetate buffer at pH 5*0 (page 95-97).
The neutral a-glucosidase, residual in Pompe fibroblasts, had
negligible activity at pH 4-0 (page 112) and treatment was unnec¬
essary, whereas the intermediate component prevented reliable
diagnosis of Pompe's disease in kidney and dextran isolated
leucocytes (page 113). Using inhibitors, it was possible to
estimate the relative activities of the acid and intermediate
components in kidney (page 129) and leucocytes (page 132). Non¬
specific |3-glucosidases of liver, not related to glucocerebrosidase
activity, could be inactivated by preincubation with 50irM-soclium
chloride buffered at pH 4*0 (page 186) enabling the reliable
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diagnosis of Gaucher's disease in this tissue using 4-methylumbell-
iferyl-|3-D-glucopyranoside. Recently it has been claimed (Turner
et al., 1977) that pH 4*0 inactivation alone is sufficient to
remove the non-specific (3-glucosidase of leucocytes. This method
was not fully reliable, but if the extract was preincubated at
pH 3.0 a result similar to that obtained with 50nM-sodium chloride
buffered at pH 4«0 was acheived (Butterworth and Broadhead, 1978)*
Peters et al. (1976) approached the problem of interfering non¬
specific (3-glucosidases by assaying at more neutral pH and in the
presence of sodium taurocholate, optimal conditions for the assay
using natural substrate.
It would seem, therefore, that if account is taken of inter¬
fering non-specific hydrolases, artificial substrates may safely
be used for the diagnosis of lysosomal storage disorders. In
some instances, however, clinically normal individuals, usually
related to affected patients have been found (Vidgoff et al.,
1975. > Dreyfus et al., 1975» Kelly et al., 1976; Wenger and
Riccardi, 1976) "to be deficient in a particular hydrolase activity.
It would seem that in these individuals, the enzyme is altered so
that it cannot effectively degrade the artificial substrate in
vitro (Vidgoff et al., 1973; Dreyfus et al., 1975) or the natural
substrate in vitro (Lott et al., 1976; Wenger and Riccardi, 1976),
but can degrade the natural substrate sufficiently in vivo.
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(ix) Suggestions for further research.
The relationship of tissue Hex-A to tissue Hex-B is now
fairly well understood. However, the nature of the relationship
of serum components to tissue components is still not clear and it
is possible that investigation of Hex-S' will elucidate the
situation. Similar studies to those of Beutler and Kuhl (1975) on
the subunits of tissue hexosaminidases are required for serum
hexosaminidases as are more detailed studies on the carbohydrate
content of serum and tissue forms.
It has been possible to estimate acid a-glucosidase in most
tissues using a variety of techniques. Some knowledge of other
a-glucosidase components has been obtained. One of these was
present in amniotic fluid but not in other enzyme sources. The
relationship of this component to other a-glucosidases (e.g. urine
a-glucosidase (Salafsky and Nadler, 1973a)) should be studied.
Further investigation of the relationship of the residual
(3-glucosidase of Gaucher fibroblasts and liver peak I to glucocer-
ebrosidase activity is required. It is unlikely that the clinical
heterogeneity of Gaucher*s disease is due to slight differences in
the amount of residual p-glucosidase activity and a different
approach may be necessary. One possibility is that the 3-glucosi¬
dase detected either by artificial substrate or natural substrate





A deficiency of this subunit (|3) would lead to an absence of
(3-glucosidase and enzyme X resulting in neuronopathic Gaucher's
disease, whereas a patient deficient in a subunits would only
lack P-glucosidase giving rise to non-neuronopathic Gaucher1s
disease. A similar model could explain the clinical differences
between adult and infantile Pompe's disease. If the model were
correct for either of these diseases, the amount of effort devoted
to understanding the hexosaminidase system will have been justified.
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Acid hydrolases were assayed by measuring the amount of the
aglycone, 4-methylumbelliferone released from a particular
4-methylumbelliferyl conjugate. The absorbance and fluorescence
characteristics of the 4-methylumbelliferyl conjugate and the
4-methylumbelliferone anion are quite different (Leaback, 1974)>
the former having peak absorbance at 330nm and peak fluorescence
at 380nm, and the latter at ^6^nm and 445nm respectively.
In the experiments described in this thesis, cell or tissue
extract was mixed with buffered substrate and after a measured
time interval the assay was stopped with 0.1M-sodium carbonate.
This not only inactivated the enzyme, but also ionised the liber¬
ated 4-methylumbelliferone to its anion. The fluorescence was
measured using either a Perkin-Elmer 203 or Perkin-Slmer 1000
spectrofluorimeter, which had been standardised using quinine
bisulphate (ipg/ml) in 0.05M-H2S0^.
6 5
4-Methylumbelliferone
Conjugates are linked at the 7 position.
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Protein Determination.
Protein was determined, "by a modification of the method of
Lowry et al. (1951) as follows:-
Reagents.
C 9ml A + 1ml B, prepared just before use.
D Polin-Ciocalteu reagent (Sigma Chemical Co.) diluted 1:5
with distilled water before use.
Protein standard: lyophylised bovine serum albumin (Sigma
Chemical Co.), 0.25mg/ml in distilled water.
Procedure.
Solution C (0.3ml) was added to 0.3ml of sample (0.05ml
extract + 0.25ml distilled water) and mixed on a vortex mixer.
After 10 minutes, 0.3ml of solution D was added with thorough
mixing on a vortex mixer and left at room temperature for 30
minutes. The extinction at 650nm was read against a no protein
blank.
A 1C96 w/v NaoC0 in 0. 5M-iia0H.2 3






Standard curve for determination of protein as above
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Tissue Culture.
All tissue culture in this thesis was carried out by the
tissue culture and cytogenetics staff of the Pathology Department
of the Royal Hospital for Sick Children, Edinburgh. Techniques
used are outlined below.
Requirements.
Ti£sue_cul_ture_medium.
The tissue culture medium (nominal volume of 5 litres) was
made up as follows:-
Ham's F10 concentrate (10x) (Plow Labs. Ltd.) 400®!
Distilled deionised water 3460ml
L-glutamine (200mM) (BDH) 40ml
Fetal bovine serum (Flow Labs. Ltd.) 720ml
Kanamycin sulphate EPC ("Kanasyn", Winthrop Labs.) Yz bottle
or Penicillin-streptomycin ("Crystamycia", Glaxo Labs.) 1 bottle
NaHCOj (4.4&) "Analar" 100ml
The medium was prepared non-sterile and filtered through a
"Millipore" filter with a pore size of 0.22p, then sterility
tested. For amniotic fluid cell primary cultures, the medium was
supplemented with more fetal bovine serum, thus raising the serum
concentration from 15% to 30%.
£ulture vessels..
Cells were cultured in baby's feeding bottles of 225ml
2
capacity and 40cm growth surface area. Amniotic fluid cell





The skin was cut up into small pieces in thrombin. Approxi¬
mately eight drops of chicken plasma were dropped onto one face
of a baby's feed bottle and a small piece of skin was placed on
each. Excess liquid was removed using a pasteur pipette. When
these drops had clotted, medium (10ml) was added and the bottle
was gassed with 5% CO^ in air. Outgrowths of fibroblasts spread
from the pieces of skin and these were subcultured.
Amnio t_ic_f'lui d_and_uxine_cells.
Cells were precipitated by centrifugation at JOOg for
10 minutes. The supernatant was poured off and the cells were
resuspended in medium, supplemented with 50% fetal bovine serum.
The cells, suspended in medium, were put into Petri dishes
(approx. 5nf- in each) . The Petri dishes were placed in
anaerobic jars (modified Mcintosh and Fildes design) and gassed
with 5% CO^ in air.
Subculture.
/ W /
Cells were removed from the culture vessel using 0.25% /v
trypsin solution (Trypsin 1:250, Difco Labs.) in phosphate
buffered saline (Dulbecco "A", Oxoid Ltd.). The cells were
centrifuged, resuspended in medium and transferred to two culture
vessels.
Cells were incubated at 37°C at all times.
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Preparation of Cultured Cells.
Requirements.
Monolayer of cultured cells.
Trypsin-versene solution, constituted as follows:




dissolved in phosphate buffered saline (PBS).
Phosphate buffered saline made from Bulbecco "A" tablets
(Oxoid Ltd.).
Procedure.
The medium was poured off the cells, which were then rinsed
once with PBS. Into each culture vessel was pipetted 5.6ml PBS
and 0.4ml trypsin/versene solution and after gentle mixing the
vessel was left on the bench with the cells on the bottom surface.
After a period of time, which depended on the cell type and the
nature of the surface of the culture vessel (plastic or glass),
the cells lifted and were transferred to a 10ml conical centrifuge
tube. The cells were sedimented by centrifugation (400g for
5 minutes) and washed twice with PBS.
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Dextran Isolated Leucocytes.
Dextran (1.4ml) ("Dextraven 110", Fisons Ltd.) was put into
a 10ml lithium heparin tube. Venous blood (8.5ml) was run into
the tube and mixed gently by inverting several times. Any bubbles
which had formed on top were burst using a red hot spatula. The
tube was left for one hour at 4°G.
After one hour, the top layer was removed leaving the
erythrocytes at'the bottom of the tube. The top layer contained
polymorphonuclear cells, the lymphocytes having been sedimented
on top of the erythrocytes. After centrifugation (900g for
5 minutes) of the top layer, a pellet of cells still heavily
contaminated with erythrocytes was obtained. The pellet was
mixed vigorously with 0.5ml of sodium chloride solution (0.2% W/v)
for thirty seconds, after which isotonicity was restored by the
/ W /
addition of 0.5ml of 1.62% /v sodium chloride. After centrifug¬
ation (900g for 5 minutes), this lysis step was repeated and
following a third centrifugation, a pellet of leucocytes relatively
free of contamination from erythrocytes was obtained.
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v
Preparation of Lymphocytes (Boyum, 1968).
Requirements.
_Si_li£oni£ed glas_s J.Oml_c£ntri1fu.g>e tube_s.
The tubes were rinsed with dimethyldichlorosilane solution,
2% in 1,1,1-trichloroethane, (BDH), drained then dried in an oven.
The tubes were then washed out to remove any excess hydrochloric
acid, rinsed in distilled water and dried in an oven.
Balanced_saPt £oluti_on_( BSS).
Two solutions (A and B) were made up as follows:-
Solution A
D-glucose (anhydrous) 0.1% W/v
CaClg. 2H20 5.0 x 10~5M
MgCl2 9-8 x 10_4M
KC1 5-4 x 10~5M
TRIS 0.145M
When one litre was required, the volume was initially made
up to 950ml and 1M-HC1 was added until pH 7was reached, after
which the solution was made up to a litre.
Solution 3
NaCl 0.14M
Balanced salt solution was a mixture of one part of solution A
with nine parts of solution B.
Pi^ol-l^Paque (Pharmacia Pine Chemicals) .
An aqueous solution of Picoll 400 (5*7g) and diatrizoate
sodium (9g) per 100ml.
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Procedure.
To each centrifuge tube was added 3ml of Ficoll-Paque.
The heparinised blood was diluted 50:50 with BSS and after
thorough mixing, 4ml was layered gently onto the Ficoll-Paque
using a Pasteur pipette. This was then centrifuged at 400g for
40 minutes at ambient temperature.
After centrifugation, the lymphocytes were at the interface
between the blood-BSS mixture and the Ficoll-Paque. The erythro¬
cytes and polymorphonuclear cells had been precipitated to the
bottom of the tube. The upper layer, which now contained diluted
plasma and platelets, was removed. The lymphocytes were transfer¬
red to another centrifuge tube, washed twice with BSS and centri¬




BE-52 (approx. 25g) was washed into a 250ml centrifuge bottle
with 0.1M-HC1 (100ml). A magnetic 'flea' was added to aid mixing
and the slurry was degassed for 5 minutes under reduced pressure.
The pH was adjusted to pH 6-7 with M-Na2HP0^ and the resin was
sedimented at 250 r.p.m. for 5 minutes. The supernatant was
decanted off and the resin was twice resuspended and washed in
50mM-sodium phosphate buffer, pH 6.0 (or 6.8). The resin was
finally suspended in lOmM-sodium phosphate buffer, pH 6.0 (or 6.8),
containing sodium azide (0.02% W/v) and Triton X-100 (0.05% V/v).
For the EEAE-cellulose batch method, the slurry was adjusted to
5C^ V/v in this buffer.
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Isoelectric Focusing in a Sucrose Gradient.
/
The method was a modification of that of Godson (1970)•
The "J-tubes" were as specified by Godson. Solutions were made
up as follows:-
Anode solution 12g sucrose, 14ml distilled water,
0.2ml orthophosphoric acid
Cathode solution 1ml ethanolamine, 50ml distilled
water
Heavy gradient 2.8g sucrose, /[.2ml distilled water,
0.06ml 1096 V/v Triton X-100,
0.75ml 10^ ampholine
Light gradient sample made up to 6ml with distilled
water, 0.06ml Mf/o V/v Triton X-100,
0.25ml ICf^ ampholine
Electrolyte dil. H^SO^ in tap water
The anode (14ml) was run into the short arm of the J-tube.
The sucrose gradient was made using a gradient mixer constructed
from two ten ml syringe barrels. The heavy gradient (4.5ml) was
first added to the mixing chamber and allowed to fill the exit
tube and the tube joining the two chambers before being clamped.
The light gradient (5ml) was then run into the second chamber.
The gradient, heavy to light, was then run gently down the long
arm of the J-tube. Cathode (approx. 2ml) was then layered on top
of the gradient.
The anode and cathode were connected to the power pack by
platinum wires dipped into the electrolyte, which was in a small
dish at the cathode and was used as a coolant for the J-tubes at
the anode (see diagram, next page). The electrolyte was connected
by platinum wires to the power pack. The voltage was raised v: •
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Schematic diagram of J-tube apparatus for sucrose gradient
isoelectric focusing.
step-wise to prevent excess current until 400v was reached. This
voltage was maintained at 4°C for 18 hours.
On completion, an airtight connection was attached to the
short arm and heavy sucrose (anode solution) was gently pumped in,
thus displacing the sucrose gradient from the long arm. Fractions
of between 8 and 12 drops were collected and the pH of each
fraction was read at 4°C.
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Glucose Oxidase Method.
Reagents were added to an LPJ tube (Luckham Ltd.) as follows:-
Sodium phosphate buffer (0.1M), pH 7«0
containing o-dianisidine-diHCl (0.1mg/ml)
and saturated with oxygen. 0.60ml
Sample or distilled water for blank. O.jOml
Horseradish peroxidase Type II (Sigma
Chemical Co.) (2mg/ml). 0.01ml
Glucose oxidase Type V from Aspergillus
niger (Sigma Chemical Co.) 0.01ml
After 45 minutes at ambient temperature, concentrated
hydrochloric acid (0.45nil) was added and the extinction at 550nm
read against a no glucose blank. With each batch a standard
curve for glucose was obtained.
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NegradativePathw ysofSphingolip ds. Cer-Glc-Gal-Gal-NAcGal (globoside) Ger-Glc-Gal-Gal (ceramidetrihexoside) Cer-PC (sphingomyelin)
Cer-Glc-Gal-NAcGal (asialoGm2)1 Cer-Glc-Gal (lactosylceramide)1 Cer-Glc (glucocerebroside)
Cer-Glc-^-al-NAcGal-Gal NANA (gmi'1 Ger-Glc-Gal-NAcGalI NANA (,GM2? Cerlc-Gal I NANA
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